{
  "nbformat": 4,
  "nbformat_minor": 0,
  "metadata": {
    "colab": {
      "name": "27.Oncology_Model.ipynb",
      "provenance": [],
      "collapsed_sections": []
    },
    "kernelspec": {
      "name": "python3",
      "display_name": "Python 3"
    },
    "language_info": {
      "name": "python"
    }
  },
  "cells": [
    {
      "cell_type": "markdown",
      "source": [
        "# Setup"
      ],
      "metadata": {
        "id": "ilNixLITXggX"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "import pandas as pd"
      ],
      "metadata": {
        "id": "QhmKnSsKaGiI"
      },
      "execution_count": 7,
      "outputs": []
    },
    {
      "cell_type": "code",
      "execution_count": 1,
      "metadata": {
        "colab": {
          "resources": {
            "http://localhost:8080/nbextensions/google.colab/files.js": {
              "data": "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",
              "ok": true,
              "headers": [
                [
                  "content-type",
                  "application/javascript"
                ]
              ],
              "status": 200,
              "status_text": ""
            }
          },
          "base_uri": "https://localhost:8080/",
          "height": 73
        },
        "id": "6Q7nbtpNWylS",
        "outputId": "e777749b-fdfa-4943-901f-2ea1d1e617a8"
      },
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<IPython.core.display.HTML object>"
            ],
            "text/html": [
              "\n",
              "     <input type=\"file\" id=\"files-733b6fb9-b07a-4658-bd41-c8b5c7cc8a17\" name=\"files[]\" multiple disabled\n",
              "        style=\"border:none\" />\n",
              "     <output id=\"result-733b6fb9-b07a-4658-bd41-c8b5c7cc8a17\">\n",
              "      Upload widget is only available when the cell has been executed in the\n",
              "      current browser session. Please rerun this cell to enable.\n",
              "      </output>\n",
              "      <script src=\"/nbextensions/google.colab/files.js\"></script> "
            ]
          },
          "metadata": {}
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Saving public344_jsl352.json to public344_jsl352.json\n"
          ]
        }
      ],
      "source": [
        "import json\n",
        "import os\n",
        "\n",
        "from google.colab import files\n",
        "\n",
        "license_keys = files.upload()\n",
        "\n",
        "with open(list(license_keys.keys())[0]) as f:\n",
        "    license_keys = json.load(f)\n",
        "\n",
        "# Defining license key-value pairs as local variables\n",
        "locals().update(license_keys)\n",
        "\n",
        "# Adding license key-value pairs to environment variables\n",
        "os.environ.update(license_keys)"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "license_keys['JSL_VERSION']"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 35
        },
        "id": "Jr8R8ta-Xr9f",
        "outputId": "6c8344b7-6eaf-4023-91ac-efa3480e18e0"
      },
      "execution_count": 2,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "'3.5.2'"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "string"
            }
          },
          "metadata": {},
          "execution_count": 2
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "license_keys['PUBLIC_VERSION']"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 35
        },
        "id": "ux2kR-IhXsLw",
        "outputId": "2b05c657-1815-443b-8387-f81fbc018f9f"
      },
      "execution_count": 3,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "'3.4.4'"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "string"
            }
          },
          "metadata": {},
          "execution_count": 3
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Installing pyspark and spark-nlp\n",
        "! pip install --upgrade -q pyspark==3.1.2 spark-nlp==$PUBLIC_VERSION\n",
        "\n",
        "# Installing Spark NLP Healthcare\n",
        "! pip install --upgrade -q spark-nlp-jsl==$JSL_VERSION  --extra-index-url https://pypi.johnsnowlabs.com/$SECRET\n",
        "\n",
        "# Installing Spark NLP Display Library for visualization\n",
        "! pip install -q spark-nlp-display"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "JgJUIasHXsTC",
        "outputId": "633a02f5-3d09-4353-baa7-abd259356206"
      },
      "execution_count": 4,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "\u001b[K     |████████████████████████████████| 212.4 MB 70 kB/s \n",
            "\u001b[K     |████████████████████████████████| 145 kB 69.4 MB/s \n",
            "\u001b[K     |████████████████████████████████| 198 kB 71.8 MB/s \n",
            "\u001b[?25h  Building wheel for pyspark (setup.py) ... \u001b[?25l\u001b[?25hdone\n",
            "\u001b[K     |████████████████████████████████| 151 kB 36.6 MB/s \n",
            "\u001b[K     |████████████████████████████████| 95 kB 4.3 MB/s \n",
            "\u001b[K     |████████████████████████████████| 66 kB 5.3 MB/s \n",
            "\u001b[?25h"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "import json\n",
        "import os\n",
        "\n",
        "import sparknlp\n",
        "import sparknlp_jsl\n",
        "\n",
        "from sparknlp.base import *\n",
        "from sparknlp.annotator import *\n",
        "from sparknlp_jsl.annotator import *\n",
        "\n",
        "from pyspark.sql import SparkSession\n",
        "from pyspark.sql import functions as F\n",
        "from pyspark.ml import Pipeline,PipelineModel\n",
        "\n",
        "import warnings\n",
        "warnings.filterwarnings('ignore')\n",
        "\n",
        "params = {\"spark.driver.memory\":\"16G\", \n",
        "          \"spark.kryoserializer.buffer.max\":\"2000M\", \n",
        "          \"spark.driver.maxResultSize\":\"2000M\"} \n",
        "\n",
        "print(\"Spark NLP Version :\", sparknlp.version())\n",
        "print(\"Spark NLP_JSL Version :\", sparknlp_jsl.version())\n",
        "\n",
        "spark = sparknlp_jsl.start(license_keys['SECRET'],params=params)\n",
        "\n",
        "spark"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 254
        },
        "id": "tmVXN4wcXshJ",
        "outputId": "198591f8-e83a-424a-cb4b-f34c8c9a0dab"
      },
      "execution_count": 5,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Spark NLP Version : 3.4.4\n",
            "Spark NLP_JSL Version : 3.5.2\n"
          ]
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "<pyspark.sql.session.SparkSession at 0x7f3c82541310>"
            ],
            "text/html": [
              "\n",
              "            <div>\n",
              "                <p><b>SparkSession - in-memory</b></p>\n",
              "                \n",
              "        <div>\n",
              "            <p><b>SparkContext</b></p>\n",
              "\n",
              "            <p><a href=\"http://7f483de22448:4040\">Spark UI</a></p>\n",
              "\n",
              "            <dl>\n",
              "              <dt>Version</dt>\n",
              "                <dd><code>v3.1.2</code></dd>\n",
              "              <dt>Master</dt>\n",
              "                <dd><code>local[*]</code></dd>\n",
              "              <dt>AppName</dt>\n",
              "                <dd><code>Spark NLP Licensed</code></dd>\n",
              "            </dl>\n",
              "        </div>\n",
              "        \n",
              "            </div>\n",
              "        "
            ]
          },
          "metadata": {},
          "execution_count": 5
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "# Sample data"
      ],
      "metadata": {
        "id": "HLqfYmL4Zg0l"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "sample_data = pd.read_json('/content/drive/MyDrive/Colab Notebooks/sample_texts.json')[0].tolist()"
      ],
      "metadata": {
        "id": "YkZSskeNYcYI"
      },
      "execution_count": 13,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "sample_data[0]"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 140
        },
        "id": "cV51_IebYcgA",
        "outputId": "16988870-2ec8-4ba8-ff51-c2911c445f2d"
      },
      "execution_count": 16,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "\"A 65-year-old Taiwanese woman had a history of debulking surgery, bilateral oophorectomy with omentectomy, total anterior hysterectomy with radical pelvic lymph nodes dissection due to ovarian carcinoma (mucinous-type carcinoma, stage Ic) 1 year ago. Patient's medical compliance was poor and failed to complete her chemotherapy (cyclophosphamide 750 mg/m2, carboplatin 300 mg/m2). Recently, she noted a palpable right breast mass, which enlarged rapidly to about 15 cm in size and nearly occupied the whole right breast in 2 months. Core needle biopsy revealed metaplastic carcinoma. Neoadjuvant chemotherapy with the regimens of Taxotere (75 mg/m2), Epirubicin (75 mg/m2), and Cyclophosphamide (500 mg/m2) was given for 6 cycles with poor response, followed by a modified radical mastectomy (MRM) with dissection of axillary lymph nodes and skin grafting. Postoperatively, radiotherapy was done with 5000 cGy in 25 fractions. The histopathologic examination revealed a metaplastic carcinoma with myoepithelial and squamous differentiation associated with adenomyoepithelioma (Figure 1A-C). Immunohistochemistry study showed that the tumor cells are positive for epithelial markers-cytokeratin (AE1/AE3) stain, and myoepithelial markers, including cytokeratin 5/6 (CK 5/6), p63, and S100 stains (Figure 2A-E). Expressions of hormone receptors, including ER, PR, and Her-2/Neu, were all negative (Figure 3A-D). The dissected axillary lymph nodes showed metastastic carcinoma with hormone triple-negative in 3 out of 26 nodes. The patient was staged as pT3N1aM0, with histologic tumor grade III.\\n\\nSeven months later, the patient complained about pain and numbness over left forearm, right lower back, and bilateral lower extremities. Fentanyl patch (2.5 mg/q72h) was used for pain control. Sonography of left forearm revealed a tumor with hypervascularity and cystic component, measuring about 6 x 5 cm in size. Positron emission tomography/computed tomography (PET/C) scan showed hypermetabolic masses in the left proximal forearm, right psoas, and quadratus lumborum muscles (Figure 4). Surgical excision of left forearm mass (Figure 5) was performed for symptomatic relief of intractable pain. However, excision for the right psoas and quadratus lumborum muscles lesion was not feasible due to high risks of morbidities. Histopathologic examination of left forearm tumor revealed metastatic carcinoma, similar to previous breast cancer with negative ER, PR, and Her-2/Neu immunostaining (Figure 3E-H), positive for epithelial markers-cytokeratin (AE1/AE3) stain, and myoepithelial markers as p63 (Figure 2F-H). Further boosted radiotherapy was added, but the metastatic tumors in the right psoas and quadratus lumborum muscles progressed in size. Eventually, lung metastasis occurred 10 months and she died 12 months later after MRM. The informed consent was obtained from the relative.\""
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "string"
            }
          },
          "metadata": {},
          "execution_count": 16
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "# Pipeline"
      ],
      "metadata": {
        "id": "R7J2D5sXaa-s"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "# White lists for assertion and entity resolution models (not all the entity types should have an assertion status or a normalized term)\n",
        "\n",
        "assertion_wl = ['ImagingTest', 'Tumor_Finding', 'Pathology_Result', 'Chemotherapy', 'Oncogene', 'Metastasis', 'PalliativeTreatment',\n",
        "                'CancerDx', 'TargetedTherapy', 'Adenopathy', 'PathologyTest', 'Biomarker', 'HormonalTherapy', 'Invasion', 'BenignTumor',\n",
        "                'SmokingStatus', 'Radiotherapy', 'CancerSurgery', 'Immunotherapy', 'HistologicalType', 'UnspecificTherapy']\n",
        "\n",
        "resolution_wl = ['SiteBrain', 'BenignTumor', 'SiteLiver', 'HistologicalType', 'Tumor_Finding', 'Pathology_Result', 'Oncogene',\n",
        "                 'SiteOtherBodyPart', 'Metastasis', 'CancerDx', 'Adenopathy', 'Invasion', 'SiteLung', 'SiteBreast', 'SiteBone', 'SiteLymphNode']"
      ],
      "metadata": {
        "id": "Ncp8dBlimNZr"
      },
      "execution_count": 64,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "documentAssembler = DocumentAssembler()\\\n",
        "  .setInputCol(\"text\")\\\n",
        "  .setOutputCol(\"document\")\n",
        "\n",
        "sentenceDetector = SentenceDetectorDLModel.pretrained(\"sentence_detector_dl_healthcare\",\"en\",\"clinical/models\")\\\n",
        "  .setInputCols([\"document\"])\\\n",
        "  .setOutputCol(\"sentence\")\n",
        "\n",
        "tokenizer = Tokenizer() \\\n",
        "    .setInputCols([\"sentence\"]) \\\n",
        "    .setOutputCol(\"token\")\n",
        "\n",
        "word_embeddings = WordEmbeddingsModel().pretrained('embeddings_clinical', 'en', 'clinical/models')\\\n",
        "    .setInputCols([\"sentence\", 'token']) \\\n",
        "    .setOutputCol(\"embeddings\")\n",
        "\n",
        "ner_oncology = MedicalNerModel.load(\"/content/drive/MyDrive/JSL/Models/oncology_model\")\\\n",
        "                    .setInputCols([\"sentence\", \"token\", \"embeddings\"])\\\n",
        "                    .setOutputCol(\"ner\")\n",
        "\n",
        "ner_converter = NerConverter()\\\n",
        "    .setInputCols([\"sentence\", \"token\", \"ner\"])\\\n",
        "    .setOutputCol(\"chunk\")\n",
        "\n",
        "ner_assertion_converter = NerConverter()\\\n",
        "    .setInputCols([\"sentence\", \"token\", \"ner\"])\\\n",
        "    .setOutputCol(\"assertion_chunk\")\\\n",
        "    .setWhiteList(assertion_wl)\n",
        "\n",
        "ner_resolution_converter = NerConverter()\\\n",
        "    .setInputCols([\"sentence\", \"token\", \"ner\"])\\\n",
        "    .setOutputCol(\"resolution_chunk\")\\\n",
        "    .setWhiteList(resolution_wl)\n",
        "\n",
        "clinical_assertion = AssertionDLModel.pretrained(\"assertion_dl_large\", \"en\", \"clinical/models\") \\\n",
        "    .setInputCols([\"sentence\", \"assertion_chunk\", \"embeddings\"]) \\\n",
        "    .setOutputCol(\"assertion\")\n",
        "\n",
        "c2doc = Chunk2Doc()\\\n",
        "    .setInputCols(\"resolution_chunk\")\\\n",
        "    .setOutputCol(\"chunk_doc\") \n",
        "\n",
        "sbert_embedder = BertSentenceEmbeddings.pretrained(\"sbiobert_base_cased_mli\", \"en\", \"clinical/models\")\\\n",
        "    .setInputCols([\"chunk_doc\"])\\\n",
        "    .setOutputCol(\"sentence_embeddings\")\n",
        "    \n",
        "resolver = SentenceEntityResolverModel.pretrained(\"sbiobertresolve_icdo_augmented\", \"en\", \"clinical/models\") \\\n",
        "    .setInputCols([\"resolution_chunk\", \"sentence_embeddings\"]) \\\n",
        "    .setOutputCol(\"resolution\")\\\n",
        "    .setDistanceFunction(\"EUCLIDEAN\")\n",
        "\n",
        "\n",
        "ner_pipeline = Pipeline(stages=[documentAssembler,\n",
        "                                sentenceDetector,\n",
        "                                tokenizer,\n",
        "                                word_embeddings, \n",
        "                                ner_oncology,\n",
        "                                ner_converter,\n",
        "                                ner_assertion_converter,\n",
        "                                ner_resolution_converter,\n",
        "                                clinical_assertion,\n",
        "                                c2doc,\n",
        "                                sbert_embedder,\n",
        "                                resolver])\n",
        "\n",
        "empty_dataframe = spark.createDataFrame([[\"\"]]).toDF(\"text\")\n",
        "\n",
        "ner_model = ner_pipeline.fit(empty_dataframe)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "N14BDH4DgM6Y",
        "outputId": "d49fb730-1be5-4698-99fb-5db42cf7966d"
      },
      "execution_count": 54,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "sentence_detector_dl_healthcare download started this may take some time.\n",
            "Approximate size to download 367.3 KB\n",
            "[OK!]\n",
            "embeddings_clinical download started this may take some time.\n",
            "Approximate size to download 1.6 GB\n",
            "[OK!]\n",
            "assertion_dl_large download started this may take some time.\n",
            "[OK!]\n",
            "sbiobert_base_cased_mli download started this may take some time.\n",
            "Approximate size to download 384.3 MB\n",
            "[OK!]\n",
            "sbiobertresolve_icdo_augmented download started this may take some time.\n",
            "[OK!]\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "light_model = LightPipeline(ner_model)"
      ],
      "metadata": {
        "id": "PEUPdzqrYctB"
      },
      "execution_count": 55,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "annotated_samples = light_model.fullAnnotate(sample_data)"
      ],
      "metadata": {
        "id": "weyu6FhSpZec"
      },
      "execution_count": 56,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "source": [
        "# Data visualization"
      ],
      "metadata": {
        "id": "fHimflFKiKfE"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "from sparknlp_display import AssertionVisualizer, EntityResolverVisualizer"
      ],
      "metadata": {
        "id": "Hb_6n8qahKkH"
      },
      "execution_count": 25,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "er_vis = EntityResolverVisualizer()\n",
        "\n",
        "assertion_vis = AssertionVisualizer()"
      ],
      "metadata": {
        "id": "_U3gbhyFlQHu"
      },
      "execution_count": 27,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "# Entities included in the NER model:\n",
        "\n",
        "entities = []\n",
        "for entity in ner_oncology.getClasses():\n",
        "  entities.append(entity.split('-')[-1])\n",
        "\n",
        "set(entities)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "tqC-x32eMJRy",
        "outputId": "43511b72-eb3e-4325-aa8f-59dce116cf23"
      },
      "execution_count": 17,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "{'Adenopathy',\n",
              " 'Age',\n",
              " 'BenignTumor',\n",
              " 'Biomarker',\n",
              " 'Biomarker_Result',\n",
              " 'CancerDx',\n",
              " 'CancerScore',\n",
              " 'CancerScoreValue',\n",
              " 'CancerSurgery',\n",
              " 'Chemotherapy',\n",
              " 'Cyclecount',\n",
              " 'Cycleday',\n",
              " 'Cycledose',\n",
              " 'Cyclelength',\n",
              " 'Cyclenumber',\n",
              " 'Date',\n",
              " 'Death_Entity',\n",
              " 'Direction',\n",
              " 'Dosage',\n",
              " 'Duration',\n",
              " 'External_body_part_or_region',\n",
              " 'Female_Reproductive_Status',\n",
              " 'Form',\n",
              " 'Frequency',\n",
              " 'Gender',\n",
              " 'Grade',\n",
              " 'HistologicalType',\n",
              " 'HormonalTherapy',\n",
              " 'ImagingTest',\n",
              " 'Immunotherapy',\n",
              " 'Internal_organ_or_component',\n",
              " 'Invasion',\n",
              " 'LineOfTherapy',\n",
              " 'Metastasis',\n",
              " 'O',\n",
              " 'Oncogene',\n",
              " 'PalliativeTreatment',\n",
              " 'PathologyTest',\n",
              " 'Pathology_Result',\n",
              " 'PerformanceStatus',\n",
              " 'Race_Ethnicity',\n",
              " 'RadiationDose',\n",
              " 'Radiotherapy',\n",
              " 'RelativeDate',\n",
              " 'RelativeTime',\n",
              " 'ResponseToTreatment',\n",
              " 'Route',\n",
              " 'SiteBone',\n",
              " 'SiteBrain',\n",
              " 'SiteBreast',\n",
              " 'SiteLiver',\n",
              " 'SiteLung',\n",
              " 'SiteLymphNode',\n",
              " 'SiteOtherBodyPart',\n",
              " 'SizeTrend',\n",
              " 'SmokingStatus',\n",
              " 'Staging',\n",
              " 'Strength',\n",
              " 'TargetedTherapy',\n",
              " 'Time',\n",
              " 'TumorSize',\n",
              " 'Tumor_Finding',\n",
              " 'UnspecificTherapy'}"
            ]
          },
          "metadata": {},
          "execution_count": 17
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "## NER + Entity Resolution"
      ],
      "metadata": {
        "id": "HPtvfSfzqyYO"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "er_vis.display(annotated_samples[0], label_col='chunk', resolution_col = 'resolution')"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "id": "UaBcD_FdkwdH",
        "outputId": "b6a4228e-5a56-4582-e2da-58ce7b233cef"
      },
      "execution_count": 57,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<IPython.core.display.HTML object>"
            ],
            "text/html": [
              "\n",
              "<style>\n",
              "    @import url('https://fonts.googleapis.com/css2?family=Montserrat:wght@300;400;500;600;700&display=swap');\n",
              "    @import url('https://fonts.googleapis.com/css2?family=Vistol Regular:wght@300;400;500;600;700&display=swap');\n",
              "    \n",
              "    .spark-nlp-display-scroll-entities {\n",
              "        border: 1px solid #E7EDF0;\n",
              "        border-radius: 3px;\n",
              "        text-align: justify;\n",
              "        \n",
              "    }\n",
              "    .spark-nlp-display-scroll-entities span {  \n",
              "        font-size: 14px;\n",
              "        line-height: 24px;\n",
              "        color: #536B76;\n",
              "        font-family: 'Montserrat', sans-serif !important;\n",
              "    }\n",
              "    \n",
              "    .spark-nlp-display-entity-wrapper{\n",
              "    \n",
              "        display: inline-grid;\n",
              "        text-align: center;\n",
              "        border-radius: 4px;\n",
              "        margin: 0 2px 5px 2px;\n",
              "        padding: 1px\n",
              "    }\n",
              "    .spark-nlp-display-entity-name{\n",
              "        font-size: 14px;\n",
              "        line-height: 24px;\n",
              "        font-family: 'Montserrat', sans-serif !important;\n",
              "        \n",
              "        background: #f1f2f3;\n",
              "        border-width: medium;\n",
              "        text-align: center;\n",
              "        \n",
              "        font-weight: 400;\n",
              "        \n",
              "        border-radius: 5px;\n",
              "        padding: 2px 5px;\n",
              "        display: block;\n",
              "        margin: 3px 2px;\n",
              "    \n",
              "    }\n",
              "    .spark-nlp-display-entity-type{\n",
              "        font-size: 14px;\n",
              "        line-height: 24px;\n",
              "        color: #ffffff;\n",
              "        font-family: 'Montserrat', sans-serif !important;\n",
              "        \n",
              "        text-transform: uppercase;\n",
              "        \n",
              "        font-weight: 500;\n",
              "\n",
              "        display: block;\n",
              "        padding: 3px 5px;\n",
              "    }\n",
              "    \n",
              "    .spark-nlp-display-entity-resolution{\n",
              "        font-size: 14px;\n",
              "        line-height: 24px;\n",
              "        color: #ffffff;\n",
              "        font-family: 'Vistol Regular', sans-serif !important;\n",
              "        \n",
              "        text-transform: uppercase;\n",
              "        \n",
              "        font-weight: 500;\n",
              "\n",
              "        display: block;\n",
              "        padding: 3px 5px;\n",
              "    }\n",
              "    \n",
              "    .spark-nlp-display-others{\n",
              "        font-size: 14px;\n",
              "        line-height: 24px;\n",
              "        font-family: 'Montserrat', sans-serif !important;\n",
              "        \n",
              "        font-weight: 400;\n",
              "    }\n",
              "\n",
              "</style>\n",
              " <span class=\"spark-nlp-display-others\" style=\"background-color: white\">A </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">65-year-old </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> Taiwanese </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">woman </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> had a history of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #5C105BB3\"><span class=\"spark-nlp-display-entity-name\">debulking surgery </span><span class=\"spark-nlp-display-entity-type\">CancerSurgery</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #31628DB3\"><span class=\"spark-nlp-display-entity-name\">bilateral </span><span class=\"spark-nlp-display-entity-type\">Direction</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #5C105BB3\"><span class=\"spark-nlp-display-entity-name\">oophorectomy </span><span class=\"spark-nlp-display-entity-type\">CancerSurgery</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #5C105BB3\"><span class=\"spark-nlp-display-entity-name\">omentectomy </span><span class=\"spark-nlp-display-entity-type\">CancerSurgery</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #5C105BB3\"><span class=\"spark-nlp-display-entity-name\">total anterior hysterectomy </span><span class=\"spark-nlp-display-entity-type\">CancerSurgery</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #5C105BB3\"><span class=\"spark-nlp-display-entity-name\">radical pelvic lymph nodes dissection </span><span class=\"spark-nlp-display-entity-type\">CancerSurgery</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> due to </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #B50CADB3\"><span class=\"spark-nlp-display-entity-name\">ovarian carcinoma </span><span class=\"spark-nlp-display-entity-type\">CancerDx</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #B50CADFF\">8441/3-C56.9 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #B50CADCC\">serous carcinoma, of ovary</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #B50CADB3\"><span class=\"spark-nlp-display-entity-name\">mucinous-type carcinoma </span><span class=\"spark-nlp-display-entity-type\">CancerDx</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #B50CADFF\">8480/3 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #B50CADCC\">mucinous carcinoma</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #5B9630B3\"><span class=\"spark-nlp-display-entity-name\">stage Ic </span><span class=\"spark-nlp-display-entity-type\">Staging</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">) </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #06777AB3\"><span class=\"spark-nlp-display-entity-name\">1 year ago </span><span class=\"spark-nlp-display-entity-type\">RelativeDate</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. Patient's medical compliance was poor and failed to complete </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">her </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #4C9FBDB3\"><span class=\"spark-nlp-display-entity-name\">chemotherapy </span><span class=\"spark-nlp-display-entity-type\">Chemotherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #4C9FBDB3\"><span class=\"spark-nlp-display-entity-name\">cyclophosphamide </span><span class=\"spark-nlp-display-entity-type\">Chemotherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #2A4A4DB3\"><span class=\"spark-nlp-display-entity-name\">750 mg/m2 </span><span class=\"spark-nlp-display-entity-type\">Dosage</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #4C9FBDB3\"><span class=\"spark-nlp-display-entity-name\">carboplatin </span><span class=\"spark-nlp-display-entity-type\">Chemotherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #2A4A4DB3\"><span class=\"spark-nlp-display-entity-name\">300 mg/m2 </span><span class=\"spark-nlp-display-entity-type\">Dosage</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">). Recently, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">she </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> noted a palpable </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #31628DB3\"><span class=\"spark-nlp-display-entity-name\">right </span><span class=\"spark-nlp-display-entity-type\">Direction</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #BEC8B8B3\"><span class=\"spark-nlp-display-entity-name\">breast </span><span class=\"spark-nlp-display-entity-type\">SiteBreast</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #BEC8B8FF\">C50 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #BEC8B8CC\">breast</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800148B3\"><span class=\"spark-nlp-display-entity-name\">mass </span><span class=\"spark-nlp-display-entity-type\">Tumor_Finding</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800148FF\">9765/1 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800148CC\">mgus</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, which enlarged rapidly to about </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #348B5FB3\"><span class=\"spark-nlp-display-entity-name\">15 cm </span><span class=\"spark-nlp-display-entity-type\">TumorSize</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> in size and nearly occupied the whole </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #31628DB3\"><span class=\"spark-nlp-display-entity-name\">right </span><span class=\"spark-nlp-display-entity-type\">Direction</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #BEC8B8B3\"><span class=\"spark-nlp-display-entity-name\">breast </span><span class=\"spark-nlp-display-entity-type\">SiteBreast</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #BEC8B8FF\">C50 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #BEC8B8CC\">breast</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #147332B3\"><span class=\"spark-nlp-display-entity-name\">in 2 months </span><span class=\"spark-nlp-display-entity-type\">Duration</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #095B87B3\"><span class=\"spark-nlp-display-entity-name\">Core needle biopsy </span><span class=\"spark-nlp-display-entity-type\">PathologyTest</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> revealed </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #594A37B3\"><span class=\"spark-nlp-display-entity-name\">metaplastic </span><span class=\"spark-nlp-display-entity-type\">HistologicalType</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #594A37FF\">8895/0 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #594A37CC\">myoma</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #B50CADB3\"><span class=\"spark-nlp-display-entity-name\">carcinoma </span><span class=\"spark-nlp-display-entity-type\">CancerDx</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #B50CADFF\">8010/3 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #B50CADCC\">carcinoma</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #4C9FBDB3\"><span class=\"spark-nlp-display-entity-name\">Neoadjuvant chemotherapy </span><span class=\"spark-nlp-display-entity-type\">Chemotherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> with the regimens of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #4C9FBDB3\"><span class=\"spark-nlp-display-entity-name\">Taxotere </span><span class=\"spark-nlp-display-entity-type\">Chemotherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #2A4A4DB3\"><span class=\"spark-nlp-display-entity-name\">75 mg/m2 </span><span class=\"spark-nlp-display-entity-type\">Dosage</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">), </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #4C9FBDB3\"><span class=\"spark-nlp-display-entity-name\">Epirubicin </span><span class=\"spark-nlp-display-entity-type\">Chemotherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #2A4A4DB3\"><span class=\"spark-nlp-display-entity-name\">75 mg/m2 </span><span class=\"spark-nlp-display-entity-type\">Dosage</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">), and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #4C9FBDB3\"><span class=\"spark-nlp-display-entity-name\">Cyclophosphamide </span><span class=\"spark-nlp-display-entity-type\">Chemotherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #2A4A4DB3\"><span class=\"spark-nlp-display-entity-name\">500 mg/m2 </span><span class=\"spark-nlp-display-entity-type\">Dosage</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">) was given for </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #1EBA69B3\"><span class=\"spark-nlp-display-entity-name\">6 cycles </span><span class=\"spark-nlp-display-entity-type\">Cyclecount</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #98B65BB3\"><span class=\"spark-nlp-display-entity-name\">poor response </span><span class=\"spark-nlp-display-entity-type\">ResponseToTreatment</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, followed by a </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #5C105BB3\"><span class=\"spark-nlp-display-entity-name\">modified radical mastectomy </span><span class=\"spark-nlp-display-entity-type\">CancerSurgery</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #5C105BB3\"><span class=\"spark-nlp-display-entity-name\">MRM </span><span class=\"spark-nlp-display-entity-type\">CancerSurgery</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">) with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #5C105BB3\"><span class=\"spark-nlp-display-entity-name\">dissection </span><span class=\"spark-nlp-display-entity-type\">CancerSurgery</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #6C368BB3\"><span class=\"spark-nlp-display-entity-name\">axillary lymph nodes </span><span class=\"spark-nlp-display-entity-type\">SiteLymphNode</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #6C368BFF\">C77.3 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #6C368BCC\">lymph nodes of axilla or arm</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #5C105BB3\"><span class=\"spark-nlp-display-entity-name\">skin grafting </span><span class=\"spark-nlp-display-entity-type\">CancerSurgery</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. Postoperatively, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #1B3D92B3\"><span class=\"spark-nlp-display-entity-name\">radiotherapy </span><span class=\"spark-nlp-display-entity-type\">Radiotherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> was done with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #0C924BB3\"><span class=\"spark-nlp-display-entity-name\">5000 cGy </span><span class=\"spark-nlp-display-entity-type\">RadiationDose</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> in 25 fractions. The </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #095B87B3\"><span class=\"spark-nlp-display-entity-name\">histopathologic examination </span><span class=\"spark-nlp-display-entity-type\">PathologyTest</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> revealed a </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #594A37B3\"><span class=\"spark-nlp-display-entity-name\">metaplastic </span><span class=\"spark-nlp-display-entity-type\">HistologicalType</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #594A37FF\">8895/0 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #594A37CC\">myoma</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #B50CADB3\"><span class=\"spark-nlp-display-entity-name\">carcinoma </span><span class=\"spark-nlp-display-entity-type\">CancerDx</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #B50CADFF\">8010/3 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #B50CADCC\">carcinoma</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> with myoepithelial and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #594A37B3\"><span class=\"spark-nlp-display-entity-name\">squamous differentiation </span><span class=\"spark-nlp-display-entity-type\">HistologicalType</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #594A37FF\">C08.1 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #594A37CC\">sublingual gland</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> associated with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #B50CADB3\"><span class=\"spark-nlp-display-entity-name\">adenomyoepithelioma </span><span class=\"spark-nlp-display-entity-type\">CancerDx</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #B50CADFF\">8983/0 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #B50CADCC\">adenomyoepithelioma</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (Figure 1A-C). </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #095B87B3\"><span class=\"spark-nlp-display-entity-name\">Immunohistochemistry study </span><span class=\"spark-nlp-display-entity-type\">PathologyTest</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> showed that the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #714298B3\"><span class=\"spark-nlp-display-entity-name\">tumor cells </span><span class=\"spark-nlp-display-entity-type\">Pathology_Result</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #714298FF\">8001/1 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #714298CC\">tumor cells</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> are </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #438C6BB3\"><span class=\"spark-nlp-display-entity-name\">positive </span><span class=\"spark-nlp-display-entity-type\">Biomarker_Result</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> for </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #955CA8B3\"><span class=\"spark-nlp-display-entity-name\">epithelial markers-cytokeratin </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #955CA8B3\"><span class=\"spark-nlp-display-entity-name\">AE1/AE3 </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">) stain, and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #955CA8B3\"><span class=\"spark-nlp-display-entity-name\">myoepithelial markers </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, including </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #955CA8B3\"><span class=\"spark-nlp-display-entity-name\">cytokeratin 5/6 </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #955CA8B3\"><span class=\"spark-nlp-display-entity-name\">CK 5/6 </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">), </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #955CA8B3\"><span class=\"spark-nlp-display-entity-name\">p63 </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #955CA8B3\"><span class=\"spark-nlp-display-entity-name\">S100 </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> stains (Figure 2A-E). Expressions of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #955CA8B3\"><span class=\"spark-nlp-display-entity-name\">hormone receptors </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, including </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #955CA8B3\"><span class=\"spark-nlp-display-entity-name\">ER </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #955CA8B3\"><span class=\"spark-nlp-display-entity-name\">PR </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, and Her-2/Neu, were all </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #438C6BB3\"><span class=\"spark-nlp-display-entity-name\">negative </span><span class=\"spark-nlp-display-entity-type\">Biomarker_Result</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (Figure 3A-D). The dissected </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #6C368BB3\"><span class=\"spark-nlp-display-entity-name\">axillary lymph nodes </span><span class=\"spark-nlp-display-entity-type\">SiteLymphNode</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #6C368BFF\">C77.3 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #6C368BCC\">lymph nodes of axilla or arm</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> showed </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #5C3004B3\"><span class=\"spark-nlp-display-entity-name\">metastastic </span><span class=\"spark-nlp-display-entity-type\">Metastasis</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #5C3004FF\">8000/6 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #5C3004CC\">tumor, metastatic</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #B50CADB3\"><span class=\"spark-nlp-display-entity-name\">carcinoma </span><span class=\"spark-nlp-display-entity-type\">CancerDx</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #B50CADFF\">8010/3 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #B50CADCC\">carcinoma</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #B50CADB3\"><span class=\"spark-nlp-display-entity-name\">hormone triple-negative </span><span class=\"spark-nlp-display-entity-type\">CancerDx</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #B50CADFF\">8730/0 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #B50CADCC\">nonpigmented nevus</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> in 3 out of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #355184B3\"><span class=\"spark-nlp-display-entity-name\">26 nodes </span><span class=\"spark-nlp-display-entity-type\">Adenopathy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #355184FF\">C14.2 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #355184CC\">waldeyer ring</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. The patient was staged as </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #5B9630B3\"><span class=\"spark-nlp-display-entity-name\">pT3N1aM0 </span><span class=\"spark-nlp-display-entity-type\">Staging</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, with histologic </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #5B9630B3\"><span class=\"spark-nlp-display-entity-name\">tumor grade III </span><span class=\"spark-nlp-display-entity-type\">Staging</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">.<br><br></span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #06777AB3\"><span class=\"spark-nlp-display-entity-name\">Seven months later </span><span class=\"spark-nlp-display-entity-type\">RelativeDate</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, the patient complained about pain and numbness over </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #31628DB3\"><span class=\"spark-nlp-display-entity-name\">left </span><span class=\"spark-nlp-display-entity-type\">Direction</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9BA2A3B3\"><span class=\"spark-nlp-display-entity-name\">forearm </span><span class=\"spark-nlp-display-entity-type\">SiteOtherBodyPart</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9BA2A3FF\">C44 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9BA2A3CC\">skin</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, right lower back, and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #31628DB3\"><span class=\"spark-nlp-display-entity-name\">bilateral </span><span class=\"spark-nlp-display-entity-type\">Direction</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9BA2A3B3\"><span class=\"spark-nlp-display-entity-name\">lower extremities </span><span class=\"spark-nlp-display-entity-type\">SiteOtherBodyPart</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9BA2A3FF\">C76.5 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9BA2A3CC\">lower limb</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. Fentanyl patch (2.5 mg/q72h) was used for pain control. </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #082D8CB3\"><span class=\"spark-nlp-display-entity-name\">Sonography of left forearm </span><span class=\"spark-nlp-display-entity-type\">ImagingTest</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> revealed a </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800148B3\"><span class=\"spark-nlp-display-entity-name\">tumor </span><span class=\"spark-nlp-display-entity-type\">Tumor_Finding</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800148FF\">8000/1 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800148CC\">tumor</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800148B3\"><span class=\"spark-nlp-display-entity-name\">hypervascularity </span><span class=\"spark-nlp-display-entity-type\">Tumor_Finding</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800148FF\">9964/3 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800148CC\">hypereosinophilic syndrome</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and cystic component, measuring about </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #348B5FB3\"><span class=\"spark-nlp-display-entity-name\">6 x 5 cm </span><span class=\"spark-nlp-display-entity-type\">TumorSize</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> in size. </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #082D8CB3\"><span class=\"spark-nlp-display-entity-name\">Positron emission tomography/computed tomography </span><span class=\"spark-nlp-display-entity-type\">ImagingTest</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (PET/C) </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #082D8CB3\"><span class=\"spark-nlp-display-entity-name\">scan </span><span class=\"spark-nlp-display-entity-type\">ImagingTest</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> showed </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800148B3\"><span class=\"spark-nlp-display-entity-name\">hypermetabolic masses </span><span class=\"spark-nlp-display-entity-type\">Tumor_Finding</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800148FF\">8312/3 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800148CC\">hypernephroma</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> in the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #31628DB3\"><span class=\"spark-nlp-display-entity-name\">left </span><span class=\"spark-nlp-display-entity-type\">Direction</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9BA2A3B3\"><span class=\"spark-nlp-display-entity-name\">proximal forearm </span><span class=\"spark-nlp-display-entity-type\">SiteOtherBodyPart</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9BA2A3FF\">C76.4 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9BA2A3CC\">upper limb</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #31628DB3\"><span class=\"spark-nlp-display-entity-name\">right </span><span class=\"spark-nlp-display-entity-type\">Direction</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9BA2A3B3\"><span class=\"spark-nlp-display-entity-name\">psoas </span><span class=\"spark-nlp-display-entity-type\">SiteOtherBodyPart</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9BA2A3FF\">9971/1 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9BA2A3CC\">ptld</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9BA2A3B3\"><span class=\"spark-nlp-display-entity-name\">quadratus lumborum muscles </span><span class=\"spark-nlp-display-entity-type\">SiteOtherBodyPart</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9BA2A3FF\">9383/1-C72.9 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9BA2A3CC\">subependymoma of nervous system</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (Figure 4). </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #5C105BB3\"><span class=\"spark-nlp-display-entity-name\">Surgical excision </span><span class=\"spark-nlp-display-entity-type\">CancerSurgery</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #31628DB3\"><span class=\"spark-nlp-display-entity-name\">left </span><span class=\"spark-nlp-display-entity-type\">Direction</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9BA2A3B3\"><span class=\"spark-nlp-display-entity-name\">forearm </span><span class=\"spark-nlp-display-entity-type\">SiteOtherBodyPart</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9BA2A3FF\">C44 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9BA2A3CC\">skin</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800148B3\"><span class=\"spark-nlp-display-entity-name\">mass </span><span class=\"spark-nlp-display-entity-type\">Tumor_Finding</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800148FF\">9765/1 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800148CC\">mgus</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (Figure 5) was performed for symptomatic relief of intractable pain. However, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #5C105BB3\"><span class=\"spark-nlp-display-entity-name\">excision </span><span class=\"spark-nlp-display-entity-type\">CancerSurgery</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> for the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #31628DB3\"><span class=\"spark-nlp-display-entity-name\">right </span><span class=\"spark-nlp-display-entity-type\">Direction</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9BA2A3B3\"><span class=\"spark-nlp-display-entity-name\">psoas </span><span class=\"spark-nlp-display-entity-type\">SiteOtherBodyPart</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9BA2A3FF\">9971/1 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9BA2A3CC\">ptld</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9BA2A3B3\"><span class=\"spark-nlp-display-entity-name\">quadratus lumborum muscles </span><span class=\"spark-nlp-display-entity-type\">SiteOtherBodyPart</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9BA2A3FF\">9383/1-C72.9 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9BA2A3CC\">subependymoma of nervous system</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800148B3\"><span class=\"spark-nlp-display-entity-name\">lesion </span><span class=\"spark-nlp-display-entity-type\">Tumor_Finding</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800148FF\">C76.8 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800148CC\">overlapping lesion of ill-defined sites</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> was not feasible due to high risks of morbidities. </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #095B87B3\"><span class=\"spark-nlp-display-entity-name\">Histopathologic examination </span><span class=\"spark-nlp-display-entity-type\">PathologyTest</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #31628DB3\"><span class=\"spark-nlp-display-entity-name\">left </span><span class=\"spark-nlp-display-entity-type\">Direction</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9BA2A3B3\"><span class=\"spark-nlp-display-entity-name\">forearm </span><span class=\"spark-nlp-display-entity-type\">SiteOtherBodyPart</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9BA2A3FF\">C44 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9BA2A3CC\">skin</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800148B3\"><span class=\"spark-nlp-display-entity-name\">tumor </span><span class=\"spark-nlp-display-entity-type\">Tumor_Finding</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800148FF\">8000/1 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800148CC\">tumor</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> revealed </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #5C3004B3\"><span class=\"spark-nlp-display-entity-name\">metastatic </span><span class=\"spark-nlp-display-entity-type\">Metastasis</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #5C3004FF\">8000/6 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #5C3004CC\">tumor, metastatic</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #B50CADB3\"><span class=\"spark-nlp-display-entity-name\">carcinoma </span><span class=\"spark-nlp-display-entity-type\">CancerDx</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #B50CADFF\">8010/3 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #B50CADCC\">carcinoma</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, similar to previous </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #B50CADB3\"><span class=\"spark-nlp-display-entity-name\">breast cancer </span><span class=\"spark-nlp-display-entity-type\">CancerDx</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #B50CADFF\">8010/3-C50.9 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #B50CADCC\">carcinoma, of breast</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #438C6BB3\"><span class=\"spark-nlp-display-entity-name\">negative </span><span class=\"spark-nlp-display-entity-type\">Biomarker_Result</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #955CA8B3\"><span class=\"spark-nlp-display-entity-name\">ER </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #955CA8B3\"><span class=\"spark-nlp-display-entity-name\">PR </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, and Her-2/Neu </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #095B87B3\"><span class=\"spark-nlp-display-entity-name\">immunostaining </span><span class=\"spark-nlp-display-entity-type\">PathologyTest</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (Figure 3E-H), </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #438C6BB3\"><span class=\"spark-nlp-display-entity-name\">positive </span><span class=\"spark-nlp-display-entity-type\">Biomarker_Result</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> for </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #955CA8B3\"><span class=\"spark-nlp-display-entity-name\">epithelial markers-cytokeratin </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #955CA8B3\"><span class=\"spark-nlp-display-entity-name\">AE1/AE3 </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">) stain, and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #955CA8B3\"><span class=\"spark-nlp-display-entity-name\">myoepithelial markers </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> as </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #955CA8B3\"><span class=\"spark-nlp-display-entity-name\">p63 </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (Figure 2F-H). Further boosted </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #1B3D92B3\"><span class=\"spark-nlp-display-entity-name\">radiotherapy </span><span class=\"spark-nlp-display-entity-type\">Radiotherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> was added, but the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #5C3004B3\"><span class=\"spark-nlp-display-entity-name\">metastatic </span><span class=\"spark-nlp-display-entity-type\">Metastasis</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #5C3004FF\">8000/6 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #5C3004CC\">tumor, metastatic</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800148B3\"><span class=\"spark-nlp-display-entity-name\">tumors </span><span class=\"spark-nlp-display-entity-type\">Tumor_Finding</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800148FF\">8000/1 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800148CC\">tumor</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> in the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #31628DB3\"><span class=\"spark-nlp-display-entity-name\">right </span><span class=\"spark-nlp-display-entity-type\">Direction</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9BA2A3B3\"><span class=\"spark-nlp-display-entity-name\">psoas </span><span class=\"spark-nlp-display-entity-type\">SiteOtherBodyPart</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9BA2A3FF\">9971/1 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9BA2A3CC\">ptld</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9BA2A3B3\"><span class=\"spark-nlp-display-entity-name\">quadratus lumborum muscles </span><span class=\"spark-nlp-display-entity-type\">SiteOtherBodyPart</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9BA2A3FF\">9383/1-C72.9 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9BA2A3CC\">subependymoma of nervous system</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> progressed in size. Eventually, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #910B14B3\"><span class=\"spark-nlp-display-entity-name\">lung </span><span class=\"spark-nlp-display-entity-type\">SiteLung</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #910B14FF\">C34.9 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #910B14CC\">lung</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #5C3004B3\"><span class=\"spark-nlp-display-entity-name\">metastasis </span><span class=\"spark-nlp-display-entity-type\">Metastasis</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #5C3004FF\">8000/6 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #5C3004CC\">tumor, metastatic</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> occurred </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #06777AB3\"><span class=\"spark-nlp-display-entity-name\">10 months </span><span class=\"spark-nlp-display-entity-type\">RelativeDate</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">she </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #052116B3\"><span class=\"spark-nlp-display-entity-name\">died </span><span class=\"spark-nlp-display-entity-type\">Death_Entity</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #06777AB3\"><span class=\"spark-nlp-display-entity-name\">12 months later after </span><span class=\"spark-nlp-display-entity-type\">RelativeDate</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #5C105BB3\"><span class=\"spark-nlp-display-entity-name\">MRM </span><span class=\"spark-nlp-display-entity-type\">CancerSurgery</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. The informed consent was obtained from the relative.</span></div>"
            ]
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "er_vis.display(annotated_samples[1], label_col='chunk', resolution_col = 'resolution')"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "id": "O6F2_WQGkwSy",
        "outputId": "2019db6b-a436-44d7-9da0-9dcf27502186"
      },
      "execution_count": 58,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<IPython.core.display.HTML object>"
            ],
            "text/html": [
              "\n",
              "<style>\n",
              "    @import url('https://fonts.googleapis.com/css2?family=Montserrat:wght@300;400;500;600;700&display=swap');\n",
              "    @import url('https://fonts.googleapis.com/css2?family=Vistol Regular:wght@300;400;500;600;700&display=swap');\n",
              "    \n",
              "    .spark-nlp-display-scroll-entities {\n",
              "        border: 1px solid #E7EDF0;\n",
              "        border-radius: 3px;\n",
              "        text-align: justify;\n",
              "        \n",
              "    }\n",
              "    .spark-nlp-display-scroll-entities span {  \n",
              "        font-size: 14px;\n",
              "        line-height: 24px;\n",
              "        color: #536B76;\n",
              "        font-family: 'Montserrat', sans-serif !important;\n",
              "    }\n",
              "    \n",
              "    .spark-nlp-display-entity-wrapper{\n",
              "    \n",
              "        display: inline-grid;\n",
              "        text-align: center;\n",
              "        border-radius: 4px;\n",
              "        margin: 0 2px 5px 2px;\n",
              "        padding: 1px\n",
              "    }\n",
              "    .spark-nlp-display-entity-name{\n",
              "        font-size: 14px;\n",
              "        line-height: 24px;\n",
              "        font-family: 'Montserrat', sans-serif !important;\n",
              "        \n",
              "        background: #f1f2f3;\n",
              "        border-width: medium;\n",
              "        text-align: center;\n",
              "        \n",
              "        font-weight: 400;\n",
              "        \n",
              "        border-radius: 5px;\n",
              "        padding: 2px 5px;\n",
              "        display: block;\n",
              "        margin: 3px 2px;\n",
              "    \n",
              "    }\n",
              "    .spark-nlp-display-entity-type{\n",
              "        font-size: 14px;\n",
              "        line-height: 24px;\n",
              "        color: #ffffff;\n",
              "        font-family: 'Montserrat', sans-serif !important;\n",
              "        \n",
              "        text-transform: uppercase;\n",
              "        \n",
              "        font-weight: 500;\n",
              "\n",
              "        display: block;\n",
              "        padding: 3px 5px;\n",
              "    }\n",
              "    \n",
              "    .spark-nlp-display-entity-resolution{\n",
              "        font-size: 14px;\n",
              "        line-height: 24px;\n",
              "        color: #ffffff;\n",
              "        font-family: 'Vistol Regular', sans-serif !important;\n",
              "        \n",
              "        text-transform: uppercase;\n",
              "        \n",
              "        font-weight: 500;\n",
              "\n",
              "        display: block;\n",
              "        padding: 3px 5px;\n",
              "    }\n",
              "    \n",
              "    .spark-nlp-display-others{\n",
              "        font-size: 14px;\n",
              "        line-height: 24px;\n",
              "        font-family: 'Montserrat', sans-serif !important;\n",
              "        \n",
              "        font-weight: 400;\n",
              "    }\n",
              "\n",
              "</style>\n",
              " <span class=\"spark-nlp-display-others\" style=\"background-color: white\">A </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">36-year-old </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">woman </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> presented at our hospital with a palpable </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #B66BA8B3\"><span class=\"spark-nlp-display-entity-name\">mass </span><span class=\"spark-nlp-display-entity-type\">Tumor_Finding</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #B66BA8FF\">9765/1 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #B66BA8CC\">mgus</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> at the external </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #05202AB3\"><span class=\"spark-nlp-display-entity-name\">left </span><span class=\"spark-nlp-display-entity-type\">Direction</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8EAE4AB3\"><span class=\"spark-nlp-display-entity-name\">breast quadrants </span><span class=\"spark-nlp-display-entity-type\">SiteBreast</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #8EAE4AFF\">C50.6 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #8EAE4ACC\">axillary tail of breast</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> in </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #a6b1e1B3\"><span class=\"spark-nlp-display-entity-name\">December 2011 </span><span class=\"spark-nlp-display-entity-type\">Date</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. The patient underwent </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #825E46B3\"><span class=\"spark-nlp-display-entity-name\">breast ultrasound </span><span class=\"spark-nlp-display-entity-type\">ImagingTest</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #825E46B3\"><span class=\"spark-nlp-display-entity-name\">breast magnetic resonance imaging </span><span class=\"spark-nlp-display-entity-type\">ImagingTest</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #825E46B3\"><span class=\"spark-nlp-display-entity-name\">MRI </span><span class=\"spark-nlp-display-entity-type\">ImagingTest</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">) that confirmed the presence of a </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #B66BA8B3\"><span class=\"spark-nlp-display-entity-name\">nodular </span><span class=\"spark-nlp-display-entity-type\">Tumor_Finding</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #B66BA8FF\">9983/3 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #B66BA8CC\">raeb</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> formation of about </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #502930B3\"><span class=\"spark-nlp-display-entity-name\">5 cm </span><span class=\"spark-nlp-display-entity-type\">TumorSize</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. In addition, at least </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #4F81BCB3\"><span class=\"spark-nlp-display-entity-name\">three lymphadenopathies </span><span class=\"spark-nlp-display-entity-type\">Adenopathy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #4F81BCFF\">9767/1-C77.8 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #4F81BCCC\">angioimmunoblastic lymphadenopathy (ail) of lymph nodes of multiple regions</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #50334AB3\"><span class=\"spark-nlp-display-entity-name\">eccentric hilum </span><span class=\"spark-nlp-display-entity-type\">SiteOtherBodyPart</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #50334AFF\">C76.4 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #50334ACC\">upper limb</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> were identified in the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #05202AB3\"><span class=\"spark-nlp-display-entity-name\">left </span><span class=\"spark-nlp-display-entity-type\">Direction</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #50334AB3\"><span class=\"spark-nlp-display-entity-name\">axillary cable </span><span class=\"spark-nlp-display-entity-type\">SiteOtherBodyPart</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #50334AFF\">C77.3 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #50334ACC\">lymph nodes of axilla or arm</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, and remote staging tests were negative. In </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #a6b1e1B3\"><span class=\"spark-nlp-display-entity-name\">January 2012 </span><span class=\"spark-nlp-display-entity-type\">Date</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #BE7560B3\"><span class=\"spark-nlp-display-entity-name\">breast biopsy </span><span class=\"spark-nlp-display-entity-type\">PathologyTest</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> diagnosed an </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #3DC82BB3\"><span class=\"spark-nlp-display-entity-name\">infiltrating </span><span class=\"spark-nlp-display-entity-type\">HistologicalType</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #3DC82BFF\">8600/0 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #3DC82BCC\">thecoma</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #3DC82BB3\"><span class=\"spark-nlp-display-entity-name\">ductal </span><span class=\"spark-nlp-display-entity-type\">HistologicalType</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #3DC82BFF\">8500/2 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #3DC82BCC\">dcis</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #99A04EB3\"><span class=\"spark-nlp-display-entity-name\">carcinoma of the breast </span><span class=\"spark-nlp-display-entity-type\">CancerDx</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #99A04EFF\">8010/3-C50.9 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #99A04ECC\">carcinoma, of breast</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #0CB60CB3\"><span class=\"spark-nlp-display-entity-name\">grade 3 </span><span class=\"spark-nlp-display-entity-type\">Grade</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #4D856EB3\"><span class=\"spark-nlp-display-entity-name\">estrogen receptor </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #4D856EB3\"><span class=\"spark-nlp-display-entity-name\">ER)-positive </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #BB7FC8B3\"><span class=\"spark-nlp-display-entity-name\">90% </span><span class=\"spark-nlp-display-entity-type\">Biomarker_Result</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">), </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #4D856EB3\"><span class=\"spark-nlp-display-entity-name\">progesterone receptor </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #7754BCB3\"><span class=\"spark-nlp-display-entity-name\">PR)-positive </span><span class=\"spark-nlp-display-entity-type\">Oncogene</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #7754BCFF\">C48.1 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #7754BCCC\">specified parts of peritoneum</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #BB7FC8B3\"><span class=\"spark-nlp-display-entity-name\">36% </span><span class=\"spark-nlp-display-entity-type\">Biomarker_Result</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">), </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #7754BCB3\"><span class=\"spark-nlp-display-entity-name\">HER2-positive </span><span class=\"spark-nlp-display-entity-type\">Oncogene</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #7754BCFF\">9100/3 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #7754BCCC\">chorionepithelioma</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #BB7FC8B3\"><span class=\"spark-nlp-display-entity-name\">3+ </span><span class=\"spark-nlp-display-entity-type\">Biomarker_Result</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> by </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #BE7560B3\"><span class=\"spark-nlp-display-entity-name\">IHC </span><span class=\"spark-nlp-display-entity-type\">PathologyTest</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">), and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #4D856EB3\"><span class=\"spark-nlp-display-entity-name\">MIB-1 36% </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. The pathological nature of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #B66BA8B3\"><span class=\"spark-nlp-display-entity-name\">lymphadenopathies </span><span class=\"spark-nlp-display-entity-type\">Tumor_Finding</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #B66BA8FF\">8563/0 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #B66BA8CC\">lymphadenoma</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> was confirmed by </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #BE7560B3\"><span class=\"spark-nlp-display-entity-name\">fine-needle aspiration </span><span class=\"spark-nlp-display-entity-type\">PathologyTest</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">.<br><br>From </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #a6b1e1B3\"><span class=\"spark-nlp-display-entity-name\">January 2012 </span><span class=\"spark-nlp-display-entity-type\">Date</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> to </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #a6b1e1B3\"><span class=\"spark-nlp-display-entity-name\">April 2012 </span><span class=\"spark-nlp-display-entity-type\">Date</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, the patient received </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #576830B3\"><span class=\"spark-nlp-display-entity-name\">neoadjuvant chemotherapy </span><span class=\"spark-nlp-display-entity-type\">Chemotherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #576830B3\"><span class=\"spark-nlp-display-entity-name\">docetaxel </span><span class=\"spark-nlp-display-entity-type\">Chemotherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #628CC6B3\"><span class=\"spark-nlp-display-entity-name\">100 mg/m2 </span><span class=\"spark-nlp-display-entity-type\">Dosage</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">) and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #AC0B45B3\"><span class=\"spark-nlp-display-entity-name\">trastuzumab </span><span class=\"spark-nlp-display-entity-type\">TargetedTherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #628CC6B3\"><span class=\"spark-nlp-display-entity-name\">8 mg/kg </span><span class=\"spark-nlp-display-entity-type\">Dosage</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> loading dose, followed by </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #628CC6B3\"><span class=\"spark-nlp-display-entity-name\">6 mg/kg </span><span class=\"spark-nlp-display-entity-type\">Dosage</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">) </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #592DB3B3\"><span class=\"spark-nlp-display-entity-name\">every three weeks </span><span class=\"spark-nlp-display-entity-type\">Frequency</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> for </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #4A555CB3\"><span class=\"spark-nlp-display-entity-name\">four cycles </span><span class=\"spark-nlp-display-entity-type\">Cyclecount</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> followed by </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #576830B3\"><span class=\"spark-nlp-display-entity-name\">cyclophosphamide </span><span class=\"spark-nlp-display-entity-type\">Chemotherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #628CC6B3\"><span class=\"spark-nlp-display-entity-name\">600 mg/m2 </span><span class=\"spark-nlp-display-entity-type\">Dosage</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">) and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #576830B3\"><span class=\"spark-nlp-display-entity-name\">doxorubicin </span><span class=\"spark-nlp-display-entity-type\">Chemotherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #628CC6B3\"><span class=\"spark-nlp-display-entity-name\">60 mg/m2 </span><span class=\"spark-nlp-display-entity-type\">Dosage</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">) </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #592DB3B3\"><span class=\"spark-nlp-display-entity-name\">every three weeks </span><span class=\"spark-nlp-display-entity-type\">Frequency</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> for </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #4A555CB3\"><span class=\"spark-nlp-display-entity-name\">four cycles </span><span class=\"spark-nlp-display-entity-type\">Cyclecount</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. The </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #4A555CB3\"><span class=\"spark-nlp-display-entity-name\">second cycle </span><span class=\"spark-nlp-display-entity-type\">Cyclecount</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #576830B3\"><span class=\"spark-nlp-display-entity-name\">chemotherapy </span><span class=\"spark-nlp-display-entity-type\">Chemotherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> was delayed due to hypertransaminasemia grade 2 (according to common terminology criteria for adverse events (CTCAE) version 5.0), treated with glutathione and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #04A5B3B3\"><span class=\"spark-nlp-display-entity-name\">prednisone 25 </span><span class=\"spark-nlp-display-entity-type\">UnspecificTherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> mg/die </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #10C359B3\"><span class=\"spark-nlp-display-entity-name\">for five days </span><span class=\"spark-nlp-display-entity-type\">Duration</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. Treatment with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #576830B3\"><span class=\"spark-nlp-display-entity-name\">docetaxel </span><span class=\"spark-nlp-display-entity-type\">Chemotherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> was resumed at 25% reduced dose, reporting only grade 1 hypertransaminasemia during subsequent </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #4A555CB3\"><span class=\"spark-nlp-display-entity-name\">cycles </span><span class=\"spark-nlp-display-entity-type\">Cyclecount</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. In </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #a6b1e1B3\"><span class=\"spark-nlp-display-entity-name\">August 2012 </span><span class=\"spark-nlp-display-entity-type\">Date</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, the patient underwent </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #05202AB3\"><span class=\"spark-nlp-display-entity-name\">bilateral </span><span class=\"spark-nlp-display-entity-type\">Direction</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #443872B3\"><span class=\"spark-nlp-display-entity-name\">mastectomy </span><span class=\"spark-nlp-display-entity-type\">CancerSurgery</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #443872B3\"><span class=\"spark-nlp-display-entity-name\">axillary node resection </span><span class=\"spark-nlp-display-entity-type\">CancerSurgery</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> with a </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #39B5C8B3\"><span class=\"spark-nlp-display-entity-name\">partial response </span><span class=\"spark-nlp-display-entity-type\">ResponseToTreatment</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> to </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #576830B3\"><span class=\"spark-nlp-display-entity-name\">neoadjuvant chemotherapy </span><span class=\"spark-nlp-display-entity-type\">Chemotherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #576830B3\"><span class=\"spark-nlp-display-entity-name\">ypT1c ypN1 Mx </span><span class=\"spark-nlp-display-entity-type\">Chemotherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">).<br><br>From </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #a6b1e1B3\"><span class=\"spark-nlp-display-entity-name\">October 2012 </span><span class=\"spark-nlp-display-entity-type\">Date</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> to </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #a6b1e1B3\"><span class=\"spark-nlp-display-entity-name\">April 2013 </span><span class=\"spark-nlp-display-entity-type\">Date</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, the patient continued </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #04A5B3B3\"><span class=\"spark-nlp-display-entity-name\">adjuvant therapy </span><span class=\"spark-nlp-display-entity-type\">UnspecificTherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #AC0B45B3\"><span class=\"spark-nlp-display-entity-name\">trastuzumab </span><span class=\"spark-nlp-display-entity-type\">TargetedTherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> administered </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #576830B3\"><span class=\"spark-nlp-display-entity-name\">subcutaneously </span><span class=\"spark-nlp-display-entity-type\">Chemotherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #628CC6B3\"><span class=\"spark-nlp-display-entity-name\">600 mg </span><span class=\"spark-nlp-display-entity-type\">Dosage</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">) </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #592DB3B3\"><span class=\"spark-nlp-display-entity-name\">every three weeks </span><span class=\"spark-nlp-display-entity-type\">Frequency</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> to </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #10C359B3\"><span class=\"spark-nlp-display-entity-name\">complete one year </span><span class=\"spark-nlp-display-entity-type\">Duration</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> of treatment and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #216B64B3\"><span class=\"spark-nlp-display-entity-name\">hormone therapy </span><span class=\"spark-nlp-display-entity-type\">HormonalTherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> with tamoxifene plus </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #216B64B3\"><span class=\"spark-nlp-display-entity-name\">luteinizing hormone-releasing hormone </span><span class=\"spark-nlp-display-entity-type\">HormonalTherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #216B64B3\"><span class=\"spark-nlp-display-entity-name\">LHRH </span><span class=\"spark-nlp-display-entity-type\">HormonalTherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">) inhibitor since </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #a6b1e1B3\"><span class=\"spark-nlp-display-entity-name\">September 2012 </span><span class=\"spark-nlp-display-entity-type\">Date</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">.<br><br>In </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #a6b1e1B3\"><span class=\"spark-nlp-display-entity-name\">January 2014 </span><span class=\"spark-nlp-display-entity-type\">Date</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, after the finding of thickening of the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #50334AB3\"><span class=\"spark-nlp-display-entity-name\">subcutaneous areola </span><span class=\"spark-nlp-display-entity-type\">SiteOtherBodyPart</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #50334AFF\">C08.1 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #50334ACC\">sublingual gland</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, the patient underwent </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #443872B3\"><span class=\"spark-nlp-display-entity-name\">surgical radical removal </span><span class=\"spark-nlp-display-entity-type\">CancerSurgery</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> of the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8EAE4AB3\"><span class=\"spark-nlp-display-entity-name\">nipple </span><span class=\"spark-nlp-display-entity-type\">SiteBreast</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #8EAE4AFF\">C50.0 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #8EAE4ACC\">nipple</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #05202AB3\"><span class=\"spark-nlp-display-entity-name\">left </span><span class=\"spark-nlp-display-entity-type\">Direction</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8EAE4AB3\"><span class=\"spark-nlp-display-entity-name\">areola </span><span class=\"spark-nlp-display-entity-type\">SiteBreast</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #8EAE4AFF\">C21.0 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #8EAE4ACC\">anus</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. The diagnosis was </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #3DC82BB3\"><span class=\"spark-nlp-display-entity-name\">intraductal </span><span class=\"spark-nlp-display-entity-type\">HistologicalType</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #3DC82BFF\">C21.0 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #3DC82BCC\">anus</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #99A04EB3\"><span class=\"spark-nlp-display-entity-name\">carcinoma </span><span class=\"spark-nlp-display-entity-type\">CancerDx</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #99A04EFF\">8010/3 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #99A04ECC\">carcinoma</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #BBB212B3\"><span class=\"spark-nlp-display-entity-name\">cribriform type in galactophore ducts of high-grade </span><span class=\"spark-nlp-display-entity-type\">Pathology_Result</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #BBB212FF\">8103/1 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #BBB212CC\">proliferating trichilemmal cyst</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> sec. WHO </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #a6b1e1B3\"><span class=\"spark-nlp-display-entity-name\">2012 </span><span class=\"spark-nlp-display-entity-type\">Date</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and Paget's disease, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #4D856EB3\"><span class=\"spark-nlp-display-entity-name\">ER 90% </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #4D856EB3\"><span class=\"spark-nlp-display-entity-name\">PgR </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #BB7FC8B3\"><span class=\"spark-nlp-display-entity-name\">negative </span><span class=\"spark-nlp-display-entity-type\">Biomarker_Result</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">.<br><br></span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">She </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> continued regular clinico-radiological follow-up, negative for locoregional and distance recurrence, until </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #a6b1e1B3\"><span class=\"spark-nlp-display-entity-name\">January 2016 </span><span class=\"spark-nlp-display-entity-type\">Date</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> when a </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #825E46B3\"><span class=\"spark-nlp-display-entity-name\">total body contrast-enhanced computed tomography </span><span class=\"spark-nlp-display-entity-type\">ImagingTest</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #825E46B3\"><span class=\"spark-nlp-display-entity-name\">CECT </span><span class=\"spark-nlp-display-entity-type\">ImagingTest</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">) </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #825E46B3\"><span class=\"spark-nlp-display-entity-name\">scan </span><span class=\"spark-nlp-display-entity-type\">ImagingTest</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and an </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #825E46B3\"><span class=\"spark-nlp-display-entity-name\">18-fluor-fluorodeoxyglucose positron emission tomography-computed tomography </span><span class=\"spark-nlp-display-entity-type\">ImagingTest</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #825E46B3\"><span class=\"spark-nlp-display-entity-name\">18F-FDG PET/CT </span><span class=\"spark-nlp-display-entity-type\">ImagingTest</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">) confirmed the presence of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #05202AB3\"><span class=\"spark-nlp-display-entity-name\">bilateral </span><span class=\"spark-nlp-display-entity-type\">Direction</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #50334AB3\"><span class=\"spark-nlp-display-entity-name\">pulmonary </span><span class=\"spark-nlp-display-entity-type\">SiteOtherBodyPart</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #50334AFF\">C34.9 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #50334ACC\">lung</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #4E6000B3\"><span class=\"spark-nlp-display-entity-name\">mediastinal pathological lymph nodes </span><span class=\"spark-nlp-display-entity-type\">SiteLymphNode</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #4E6000FF\">8000/3-C77.1 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #4E6000CC\">neoplasm, malignant of intrathoracic lymph nodes</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #95743FB3\"><span class=\"spark-nlp-display-entity-name\">bone </span><span class=\"spark-nlp-display-entity-type\">SiteBone</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #95743FFF\">C41.9 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #95743FCC\">bone</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #78A473B3\"><span class=\"spark-nlp-display-entity-name\">metastases </span><span class=\"spark-nlp-display-entity-type\">Metastasis</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #78A473FF\">8000/6 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #78A473CC\">tumor, metastatic</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. According to the disease stage, biomolecular </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #B66BA8B3\"><span class=\"spark-nlp-display-entity-name\">tumor </span><span class=\"spark-nlp-display-entity-type\">Tumor_Finding</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #B66BA8FF\">8000/1 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #B66BA8CC\">tumor</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> characteristics, and clinical conditions (PS 0 sec. </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #12485FB3\"><span class=\"spark-nlp-display-entity-name\">ECOG </span><span class=\"spark-nlp-display-entity-type\">Staging</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">), in </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #a6b1e1B3\"><span class=\"spark-nlp-display-entity-name\">January 2016 </span><span class=\"spark-nlp-display-entity-type\">Date</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, the patient started </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #04A5B3B3\"><span class=\"spark-nlp-display-entity-name\">first-line therapy </span><span class=\"spark-nlp-display-entity-type\">UnspecificTherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #AC0B45B3\"><span class=\"spark-nlp-display-entity-name\">pertuzumab </span><span class=\"spark-nlp-display-entity-type\">TargetedTherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> plus </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #AC0B45B3\"><span class=\"spark-nlp-display-entity-name\">trastuzumab </span><span class=\"spark-nlp-display-entity-type\">TargetedTherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #576830B3\"><span class=\"spark-nlp-display-entity-name\">docetaxel </span><span class=\"spark-nlp-display-entity-type\">Chemotherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #592DB3B3\"><span class=\"spark-nlp-display-entity-name\">every three weeks </span><span class=\"spark-nlp-display-entity-type\">Frequency</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> at standard doses. </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">She </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> reassumed the same regimen up to </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #4A555CB3\"><span class=\"spark-nlp-display-entity-name\">four courses </span><span class=\"spark-nlp-display-entity-type\">Cyclecount</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and then </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">she </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> continued with dual HER2-blockage for a further </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #4A555CB3\"><span class=\"spark-nlp-display-entity-name\">three cycles </span><span class=\"spark-nlp-display-entity-type\">Cyclecount</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. The </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #825E46B3\"><span class=\"spark-nlp-display-entity-name\">CECT scan </span><span class=\"spark-nlp-display-entity-type\">ImagingTest</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> after </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #4A555CB3\"><span class=\"spark-nlp-display-entity-name\">three courses </span><span class=\"spark-nlp-display-entity-type\">Cyclecount</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> of treatment showed a </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #39B5C8B3\"><span class=\"spark-nlp-display-entity-name\">partial response </span><span class=\"spark-nlp-display-entity-type\">ResponseToTreatment</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, but after the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #6D8591B3\"><span class=\"spark-nlp-display-entity-name\">second cycle </span><span class=\"spark-nlp-display-entity-type\">Cyclenumber</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> the patient showed grade 2 mucositis and grade 3 hypertransaminasemia, treated with glutathione and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #04A5B3B3\"><span class=\"spark-nlp-display-entity-name\">prednisone </span><span class=\"spark-nlp-display-entity-type\">UnspecificTherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #628CC6B3\"><span class=\"spark-nlp-display-entity-name\">25 mg/die </span><span class=\"spark-nlp-display-entity-type\">Dosage</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #10C359B3\"><span class=\"spark-nlp-display-entity-name\">for five days </span><span class=\"spark-nlp-display-entity-type\">Duration</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, and the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #6D8591B3\"><span class=\"spark-nlp-display-entity-name\">third cycle </span><span class=\"spark-nlp-display-entity-type\">Cyclenumber</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> was delayed. Antigens of hepatitis were tested and resulted negative.<br><br>In </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #a6b1e1B3\"><span class=\"spark-nlp-display-entity-name\">August 2016 </span><span class=\"spark-nlp-display-entity-type\">Date</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, an </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #825E46B3\"><span class=\"spark-nlp-display-entity-name\">18F-FDG PET/CT </span><span class=\"spark-nlp-display-entity-type\">ImagingTest</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> revealed </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #4E6000B3\"><span class=\"spark-nlp-display-entity-name\">lymph node </span><span class=\"spark-nlp-display-entity-type\">SiteLymphNode</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #4E6000FF\">C77.9 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #4E6000CC\">lymph node</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #95743FB3\"><span class=\"spark-nlp-display-entity-name\">bone </span><span class=\"spark-nlp-display-entity-type\">SiteBone</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #95743FFF\">C41.9 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #95743FCC\">bone</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #39B5C8B3\"><span class=\"spark-nlp-display-entity-name\">progression disease </span><span class=\"spark-nlp-display-entity-type\">ResponseToTreatment</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. Thus, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">she </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> started </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #04A5B3B3\"><span class=\"spark-nlp-display-entity-name\">second-line therapy </span><span class=\"spark-nlp-display-entity-type\">UnspecificTherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #AC0B45B3\"><span class=\"spark-nlp-display-entity-name\">T-DM1 </span><span class=\"spark-nlp-display-entity-type\">TargetedTherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> at </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #628CC6B3\"><span class=\"spark-nlp-display-entity-name\">3.6 mg/kg </span><span class=\"spark-nlp-display-entity-type\">Dosage</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #592DB3B3\"><span class=\"spark-nlp-display-entity-name\">every three weeks </span><span class=\"spark-nlp-display-entity-type\">Frequency</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> with concurrent </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #AC0B45B3\"><span class=\"spark-nlp-display-entity-name\">denosumab </span><span class=\"spark-nlp-display-entity-type\">TargetedTherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #592DB3B3\"><span class=\"spark-nlp-display-entity-name\">every four weeks </span><span class=\"spark-nlp-display-entity-type\">Frequency</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. From </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #a6b1e1B3\"><span class=\"spark-nlp-display-entity-name\">August 2016 </span><span class=\"spark-nlp-display-entity-type\">Date</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> to </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #a6b1e1B3\"><span class=\"spark-nlp-display-entity-name\">April 2018 </span><span class=\"spark-nlp-display-entity-type\">Date</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">she </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> received </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #4A555CB3\"><span class=\"spark-nlp-display-entity-name\">28 cycles </span><span class=\"spark-nlp-display-entity-type\">Cyclecount</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. After the ninth cycle, due to the occurrence of grade 2 hypertransaminasemia, glutathione was introduced in </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #576830B3\"><span class=\"spark-nlp-display-entity-name\">chemotherapy </span><span class=\"spark-nlp-display-entity-type\">Chemotherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> regimens with the resolution of toxicity.<br><br>In </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #a6b1e1B3\"><span class=\"spark-nlp-display-entity-name\">April 2018 </span><span class=\"spark-nlp-display-entity-type\">Date</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, due to a </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #4E6000B3\"><span class=\"spark-nlp-display-entity-name\">lymph node </span><span class=\"spark-nlp-display-entity-type\">SiteLymphNode</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #4E6000FF\">C77.9 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #4E6000CC\">lymph node</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9D4249B3\"><span class=\"spark-nlp-display-entity-name\">lung </span><span class=\"spark-nlp-display-entity-type\">SiteLung</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9D4249FF\">C34.9 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9D4249CC\">lung</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #39B5C8B3\"><span class=\"spark-nlp-display-entity-name\">disease progression </span><span class=\"spark-nlp-display-entity-type\">ResponseToTreatment</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, the patient was enrolled in the phase III clinical trial SOPHIA (NCT02492711) and randomized to the control arm. The screening laboratory findings showed a grade 3 hypertransaminasemia that was treated with glutathione infusion. At the resolution of toxicity, since the patient had been randomized into the control arm, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">she </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> began treatment with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #AC0B45B3\"><span class=\"spark-nlp-display-entity-name\">trastuzumab </span><span class=\"spark-nlp-display-entity-type\">TargetedTherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #628CC6B3\"><span class=\"spark-nlp-display-entity-name\">8 mg/kg </span><span class=\"spark-nlp-display-entity-type\">Dosage</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> loading dose, followed by </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #628CC6B3\"><span class=\"spark-nlp-display-entity-name\">6 mg/kg </span><span class=\"spark-nlp-display-entity-type\">Dosage</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">) and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #576830B3\"><span class=\"spark-nlp-display-entity-name\">navelbine </span><span class=\"spark-nlp-display-entity-type\">Chemotherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #628CC6B3\"><span class=\"spark-nlp-display-entity-name\">25 mg/mq d1-8 </span><span class=\"spark-nlp-display-entity-type\">Dosage</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #592DB3B3\"><span class=\"spark-nlp-display-entity-name\">every three weeks </span><span class=\"spark-nlp-display-entity-type\">Frequency</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">). The treatment was poorly tolerated with grade 4 neutropenia and grade 2 anemia after the first cycle and grade 4 neutropenia after the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #6D8591B3\"><span class=\"spark-nlp-display-entity-name\">second cycle </span><span class=\"spark-nlp-display-entity-type\">Cyclenumber</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> with 50% dose reduction and secondary prophylaxis with granulocyte colony-stimulating factor (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #576830B3\"><span class=\"spark-nlp-display-entity-name\">G-CSF </span><span class=\"spark-nlp-display-entity-type\">Chemotherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">). Due to hematological toxicities, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">she </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> continued treatment without </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #576830B3\"><span class=\"spark-nlp-display-entity-name\">navelbine </span><span class=\"spark-nlp-display-entity-type\">Chemotherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">she </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> received </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #4A555CB3\"><span class=\"spark-nlp-display-entity-name\">four courses </span><span class=\"spark-nlp-display-entity-type\">Cyclecount</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #AC0B45B3\"><span class=\"spark-nlp-display-entity-name\">trastuzumab </span><span class=\"spark-nlp-display-entity-type\">TargetedTherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">.<br><br>In </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #a6b1e1B3\"><span class=\"spark-nlp-display-entity-name\">October 2018 </span><span class=\"spark-nlp-display-entity-type\">Date</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, a further </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #4E6000B3\"><span class=\"spark-nlp-display-entity-name\">lymph node </span><span class=\"spark-nlp-display-entity-type\">SiteLymphNode</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #4E6000FF\">C77.9 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #4E6000CC\">lymph node</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9D4249B3\"><span class=\"spark-nlp-display-entity-name\">lung </span><span class=\"spark-nlp-display-entity-type\">SiteLung</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9D4249FF\">C34.9 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9D4249CC\">lung</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #39B5C8B3\"><span class=\"spark-nlp-display-entity-name\">disease progression </span><span class=\"spark-nlp-display-entity-type\">ResponseToTreatment</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> was detected, and then </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">she </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> started </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #6A7F7CB3\"><span class=\"spark-nlp-display-entity-name\">fourth line </span><span class=\"spark-nlp-display-entity-type\">LineOfTherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #576830B3\"><span class=\"spark-nlp-display-entity-name\">capecitabine </span><span class=\"spark-nlp-display-entity-type\">Chemotherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #628CC6B3\"><span class=\"spark-nlp-display-entity-name\">1000 mg/mq </span><span class=\"spark-nlp-display-entity-type\">Dosage</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #592DB3B3\"><span class=\"spark-nlp-display-entity-name\">bid d1-14 </span><span class=\"spark-nlp-display-entity-type\">Frequency</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">) plus </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #AC0B45B3\"><span class=\"spark-nlp-display-entity-name\">lapatinib </span><span class=\"spark-nlp-display-entity-type\">TargetedTherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #628CC6B3\"><span class=\"spark-nlp-display-entity-name\">1250 mg </span><span class=\"spark-nlp-display-entity-type\">Dosage</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #592DB3B3\"><span class=\"spark-nlp-display-entity-name\">once daily </span><span class=\"spark-nlp-display-entity-type\">Frequency</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">) </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #592DB3B3\"><span class=\"spark-nlp-display-entity-name\">every three weeks </span><span class=\"spark-nlp-display-entity-type\">Frequency</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. The patient received IX cycle from </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #a6b1e1B3\"><span class=\"spark-nlp-display-entity-name\">November 2018 </span><span class=\"spark-nlp-display-entity-type\">Date</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> to </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #a6b1e1B3\"><span class=\"spark-nlp-display-entity-name\">June 2019 </span><span class=\"spark-nlp-display-entity-type\">Date</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. After the first cycle, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">she </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> presented grade 1 hypertransaminasemia, which was resolved with glutathione infusion.<br><br>After a further </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #4E6000B3\"><span class=\"spark-nlp-display-entity-name\">lymph node </span><span class=\"spark-nlp-display-entity-type\">SiteLymphNode</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #4E6000FF\">C77.9 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #4E6000CC\">lymph node</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9D4249B3\"><span class=\"spark-nlp-display-entity-name\">lung </span><span class=\"spark-nlp-display-entity-type\">SiteLung</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9D4249FF\">C34.9 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9D4249CC\">lung</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #39B5C8B3\"><span class=\"spark-nlp-display-entity-name\">disease progression </span><span class=\"spark-nlp-display-entity-type\">ResponseToTreatment</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">she </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> received </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #04A5B3B3\"><span class=\"spark-nlp-display-entity-name\">fifth-line therapy </span><span class=\"spark-nlp-display-entity-type\">UnspecificTherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #576830B3\"><span class=\"spark-nlp-display-entity-name\">nab-paclitaxel </span><span class=\"spark-nlp-display-entity-type\">Chemotherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #628CC6B3\"><span class=\"spark-nlp-display-entity-name\">260 mg/m2 </span><span class=\"spark-nlp-display-entity-type\">Dosage</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #AC0B45B3\"><span class=\"spark-nlp-display-entity-name\">trastuzumab </span><span class=\"spark-nlp-display-entity-type\">TargetedTherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #592DB3B3\"><span class=\"spark-nlp-display-entity-name\">every three weeks </span><span class=\"spark-nlp-display-entity-type\">Frequency</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> with primary prophylaxis with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #576830B3\"><span class=\"spark-nlp-display-entity-name\">G-CSF </span><span class=\"spark-nlp-display-entity-type\">Chemotherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">She </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> received </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #4A555CB3\"><span class=\"spark-nlp-display-entity-name\">nine courses </span><span class=\"spark-nlp-display-entity-type\">Cyclecount</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> from </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #a6b1e1B3\"><span class=\"spark-nlp-display-entity-name\">July 2019 </span><span class=\"spark-nlp-display-entity-type\">Date</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> to </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #a6b1e1B3\"><span class=\"spark-nlp-display-entity-name\">December 2019 </span><span class=\"spark-nlp-display-entity-type\">Date</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">she </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> presented only grade 1 hypertransaminasemia.<br><br>Due to the evidence of complete response and the patient's preference to discontinue alopecitizing </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #576830B3\"><span class=\"spark-nlp-display-entity-name\">chemotherapy </span><span class=\"spark-nlp-display-entity-type\">Chemotherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">she </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> continued treatment with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #AC0B45B3\"><span class=\"spark-nlp-display-entity-name\">trastuzumab </span><span class=\"spark-nlp-display-entity-type\">TargetedTherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> alone until </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #a6b1e1B3\"><span class=\"spark-nlp-display-entity-name\">March 2020 </span><span class=\"spark-nlp-display-entity-type\">Date</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, when an </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #825E46B3\"><span class=\"spark-nlp-display-entity-name\">18F-FDG PET/CT </span><span class=\"spark-nlp-display-entity-type\">ImagingTest</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> revealed </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #4E6000B3\"><span class=\"spark-nlp-display-entity-name\">lymph node </span><span class=\"spark-nlp-display-entity-type\">SiteLymphNode</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #4E6000FF\">C77.9 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #4E6000CC\">lymph node</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9D4249B3\"><span class=\"spark-nlp-display-entity-name\">lung </span><span class=\"spark-nlp-display-entity-type\">SiteLung</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9D4249FF\">C34.9 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9D4249CC\">lung</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #39B5C8B3\"><span class=\"spark-nlp-display-entity-name\">relapse </span><span class=\"spark-nlp-display-entity-type\">ResponseToTreatment</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. Then, in </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #a6b1e1B3\"><span class=\"spark-nlp-display-entity-name\">April 2020 </span><span class=\"spark-nlp-display-entity-type\">Date</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">she </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> started </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #04A5B3B3\"><span class=\"spark-nlp-display-entity-name\">sixth-line therapy </span><span class=\"spark-nlp-display-entity-type\">UnspecificTherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #576830B3\"><span class=\"spark-nlp-display-entity-name\">gemcitabine </span><span class=\"spark-nlp-display-entity-type\">Chemotherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #628CC6B3\"><span class=\"spark-nlp-display-entity-name\">1000 mg/m2 d1 </span><span class=\"spark-nlp-display-entity-type\">Dosage</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #7E3AA7B3\"><span class=\"spark-nlp-display-entity-name\">d8 </span><span class=\"spark-nlp-display-entity-type\">Cycleday</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> plus </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #AC0B45B3\"><span class=\"spark-nlp-display-entity-name\">trastuzumab </span><span class=\"spark-nlp-display-entity-type\">TargetedTherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #628CC6B3\"><span class=\"spark-nlp-display-entity-name\">6 mg/kg </span><span class=\"spark-nlp-display-entity-type\">Dosage</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #592DB3B3\"><span class=\"spark-nlp-display-entity-name\">every three weeks </span><span class=\"spark-nlp-display-entity-type\">Frequency</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. After the first cycle, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">she </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> presented grade 2 hypertransaminasemia and grade 2 thrombocytopenia, so </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">she </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> stopped the treatment; due to the occurrence of pain in the left arm (VAS 8), we prescribed oxycodone plus naloxone. At the fourth cycle, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">she </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> showed grade 3 hypertransaminasemia, and we decided to reduce </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #576830B3\"><span class=\"spark-nlp-display-entity-name\">gemcitabine </span><span class=\"spark-nlp-display-entity-type\">Chemotherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> dose, but the toxicity persisted. Therefore, liver virology was tested again. Moreover, at this time point (Figure 1), since the new technology for DDGI had become available at our center, we evaluated </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">her </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> genomic polymorphisms, including genes encoding for the main drug metabolism enzymes, and simultaneously analyzed all </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">her </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> clinical, biochemical, and genomic data by using the new Drug-PIN system comprehensive approach ( (accessed on 31 </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #a6b1e1B3\"><span class=\"spark-nlp-display-entity-name\">March 2020 </span><span class=\"spark-nlp-display-entity-type\">Date</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">)) In particular, for the SNP analysis, the patient's DNA was extracted from samples of 5 mL of peripheral blood, using the automatic QIAsymphony system for the extraction of nucleic acid (Qiagen, Hilden, Germany), and then the latter was processed using a next-generation sequencing platform Ion Chef/Ion S5 system (Thermo Fisher Scientific, Waltham, MA, USA) according to the manufacturer's instructions.<br><br>Due to the results of the analysis (Table S1), we decided to maintain the reduced dose of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #576830B3\"><span class=\"spark-nlp-display-entity-name\">gemcitabine </span><span class=\"spark-nlp-display-entity-type\">Chemotherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and to introduce glutathione as part of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #216B64B3\"><span class=\"spark-nlp-display-entity-name\">cancer treatment </span><span class=\"spark-nlp-display-entity-type\">HormonalTherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> from the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #4A555CB3\"><span class=\"spark-nlp-display-entity-name\">sixth cycle </span><span class=\"spark-nlp-display-entity-type\">Cyclecount</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #576830B3\"><span class=\"spark-nlp-display-entity-name\">chemotherapy </span><span class=\"spark-nlp-display-entity-type\">Chemotherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">.<br><br>From </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #a6b1e1B3\"><span class=\"spark-nlp-display-entity-name\">August to December 2020 </span><span class=\"spark-nlp-display-entity-type\">Date</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, the patient received 25% reduced dose </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #576830B3\"><span class=\"spark-nlp-display-entity-name\">gemcitabine </span><span class=\"spark-nlp-display-entity-type\">Chemotherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> with four vials of glutathione, and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">she </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> showed maximum grade 2 liver toxicity.<br><br>In </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #a6b1e1B3\"><span class=\"spark-nlp-display-entity-name\">December 2020 </span><span class=\"spark-nlp-display-entity-type\">Date</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, an </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #825E46B3\"><span class=\"spark-nlp-display-entity-name\">18F-FDG PET/CT </span><span class=\"spark-nlp-display-entity-type\">ImagingTest</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> evaluation revealed </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #443872B3\"><span class=\"spark-nlp-display-entity-name\">oligometastatic lymph node </span><span class=\"spark-nlp-display-entity-type\">CancerSurgery</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #95743FB3\"><span class=\"spark-nlp-display-entity-name\">bone </span><span class=\"spark-nlp-display-entity-type\">SiteBone</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #95743FFF\">C41.9 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #95743FCC\">bone</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #39B5C8B3\"><span class=\"spark-nlp-display-entity-name\">progression </span><span class=\"spark-nlp-display-entity-type\">ResponseToTreatment</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">; therefore, we decided to treat with local </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #589142B3\"><span class=\"spark-nlp-display-entity-name\">radiotherapy </span><span class=\"spark-nlp-display-entity-type\">Radiotherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> on sternal dumbbell and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #05202AB3\"><span class=\"spark-nlp-display-entity-name\">left </span><span class=\"spark-nlp-display-entity-type\">Direction</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> later-cervical, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #50334AB3\"><span class=\"spark-nlp-display-entity-name\">supraclavicular </span><span class=\"spark-nlp-display-entity-type\">SiteOtherBodyPart</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #50334AFF\">C13.0 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #50334ACC\">postcricoid region</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, and retro-pectoral </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #4E6000B3\"><span class=\"spark-nlp-display-entity-name\">lymph nodes </span><span class=\"spark-nlp-display-entity-type\">SiteLymphNode</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #4E6000FF\">C77 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #4E6000CC\">lymph nodes</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, maintaining the same </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #576830B3\"><span class=\"spark-nlp-display-entity-name\">chemotherapy </span><span class=\"spark-nlp-display-entity-type\">Chemotherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> regimen. Today, the treatment with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #576830B3\"><span class=\"spark-nlp-display-entity-name\">gemcitabine </span><span class=\"spark-nlp-display-entity-type\">Chemotherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #AC0B45B3\"><span class=\"spark-nlp-display-entity-name\">trastuzumab </span><span class=\"spark-nlp-display-entity-type\">TargetedTherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> is still ongoing, and the patient has reported an overall survival (OS) of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #10C359B3\"><span class=\"spark-nlp-display-entity-name\">111 months </span><span class=\"spark-nlp-display-entity-type\">Duration</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> from first diagnosis and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #10C359B3\"><span class=\"spark-nlp-display-entity-name\">of 50 months </span><span class=\"spark-nlp-display-entity-type\">Duration</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> from recurrence.</span></div>"
            ]
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "er_vis.display(annotated_samples[2], label_col='chunk', resolution_col = 'resolution')"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "id": "ikaqGntskvxz",
        "outputId": "7869d163-1af7-458d-9790-bd2223f05c1c"
      },
      "execution_count": 59,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<IPython.core.display.HTML object>"
            ],
            "text/html": [
              "\n",
              "<style>\n",
              "    @import url('https://fonts.googleapis.com/css2?family=Montserrat:wght@300;400;500;600;700&display=swap');\n",
              "    @import url('https://fonts.googleapis.com/css2?family=Vistol Regular:wght@300;400;500;600;700&display=swap');\n",
              "    \n",
              "    .spark-nlp-display-scroll-entities {\n",
              "        border: 1px solid #E7EDF0;\n",
              "        border-radius: 3px;\n",
              "        text-align: justify;\n",
              "        \n",
              "    }\n",
              "    .spark-nlp-display-scroll-entities span {  \n",
              "        font-size: 14px;\n",
              "        line-height: 24px;\n",
              "        color: #536B76;\n",
              "        font-family: 'Montserrat', sans-serif !important;\n",
              "    }\n",
              "    \n",
              "    .spark-nlp-display-entity-wrapper{\n",
              "    \n",
              "        display: inline-grid;\n",
              "        text-align: center;\n",
              "        border-radius: 4px;\n",
              "        margin: 0 2px 5px 2px;\n",
              "        padding: 1px\n",
              "    }\n",
              "    .spark-nlp-display-entity-name{\n",
              "        font-size: 14px;\n",
              "        line-height: 24px;\n",
              "        font-family: 'Montserrat', sans-serif !important;\n",
              "        \n",
              "        background: #f1f2f3;\n",
              "        border-width: medium;\n",
              "        text-align: center;\n",
              "        \n",
              "        font-weight: 400;\n",
              "        \n",
              "        border-radius: 5px;\n",
              "        padding: 2px 5px;\n",
              "        display: block;\n",
              "        margin: 3px 2px;\n",
              "    \n",
              "    }\n",
              "    .spark-nlp-display-entity-type{\n",
              "        font-size: 14px;\n",
              "        line-height: 24px;\n",
              "        color: #ffffff;\n",
              "        font-family: 'Montserrat', sans-serif !important;\n",
              "        \n",
              "        text-transform: uppercase;\n",
              "        \n",
              "        font-weight: 500;\n",
              "\n",
              "        display: block;\n",
              "        padding: 3px 5px;\n",
              "    }\n",
              "    \n",
              "    .spark-nlp-display-entity-resolution{\n",
              "        font-size: 14px;\n",
              "        line-height: 24px;\n",
              "        color: #ffffff;\n",
              "        font-family: 'Vistol Regular', sans-serif !important;\n",
              "        \n",
              "        text-transform: uppercase;\n",
              "        \n",
              "        font-weight: 500;\n",
              "\n",
              "        display: block;\n",
              "        padding: 3px 5px;\n",
              "    }\n",
              "    \n",
              "    .spark-nlp-display-others{\n",
              "        font-size: 14px;\n",
              "        line-height: 24px;\n",
              "        font-family: 'Montserrat', sans-serif !important;\n",
              "        \n",
              "        font-weight: 400;\n",
              "    }\n",
              "\n",
              "</style>\n",
              " <span class=\"spark-nlp-display-others\" style=\"background-color: white\">The patient, a </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">29-year-old </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">male </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, discovered a painless half-peanut-size </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8AC64CB3\"><span class=\"spark-nlp-display-entity-name\">nodule </span><span class=\"spark-nlp-display-entity-type\">Tumor_Finding</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #8AC64CFF\">8720/0 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #8AC64CCC\">nevus</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> in </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">his </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #302C98B3\"><span class=\"spark-nlp-display-entity-name\">left </span><span class=\"spark-nlp-display-entity-type\">Direction</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #A2496AB3\"><span class=\"spark-nlp-display-entity-name\">axilla </span><span class=\"spark-nlp-display-entity-type\">SiteOtherBodyPart</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A2496AFF\">C50.6 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A2496ACC\">axillary tail of breast</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> in </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #a6b1e1B3\"><span class=\"spark-nlp-display-entity-name\">April 2014 </span><span class=\"spark-nlp-display-entity-type\">Date</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. The patient was not concerned because of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">his </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> busy </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #47BE81B3\"><span class=\"spark-nlp-display-entity-name\">daily </span><span class=\"spark-nlp-display-entity-type\">Frequency</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> work schedule. The size of the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8AC64CB3\"><span class=\"spark-nlp-display-entity-name\">nodule </span><span class=\"spark-nlp-display-entity-type\">Tumor_Finding</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #8AC64CFF\">8720/0 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #8AC64CCC\">nevus</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> gradually increased in the following year. In </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #a6b1e1B3\"><span class=\"spark-nlp-display-entity-name\">March 2016 </span><span class=\"spark-nlp-display-entity-type\">Date</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">he </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> went to a local hospital near </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">his </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> home for a medical checkup and exhibiting 2 walnut-sized palpable </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8AC64CB3\"><span class=\"spark-nlp-display-entity-name\">masses </span><span class=\"spark-nlp-display-entity-type\">Tumor_Finding</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #8AC64CFF\">C76.1 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #8AC64CCC\">thorax</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8F9F33B3\"><span class=\"spark-nlp-display-entity-name\">Ultrasonographic </span><span class=\"spark-nlp-display-entity-type\">ImagingTest</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8F9F33B3\"><span class=\"spark-nlp-display-entity-name\">US </span><span class=\"spark-nlp-display-entity-type\">ImagingTest</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">) examination revealed 3 hypoechoic solid </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8AC64CB3\"><span class=\"spark-nlp-display-entity-name\">masses </span><span class=\"spark-nlp-display-entity-type\">Tumor_Finding</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #8AC64CFF\">C76.1 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #8AC64CCC\">thorax</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> with clear boundaries in the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #302C98B3\"><span class=\"spark-nlp-display-entity-name\">left </span><span class=\"spark-nlp-display-entity-type\">Direction</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #A2496AB3\"><span class=\"spark-nlp-display-entity-name\">axillary cavity </span><span class=\"spark-nlp-display-entity-type\">SiteOtherBodyPart</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A2496AFF\">C77.3 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A2496ACC\">lymph nodes of axilla or arm</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (Fig. 1); the largest </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8AC64CB3\"><span class=\"spark-nlp-display-entity-name\">mass </span><span class=\"spark-nlp-display-entity-type\">Tumor_Finding</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #8AC64CFF\">9765/1 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #8AC64CCC\">mgus</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> was </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #6C8F7AB3\"><span class=\"spark-nlp-display-entity-name\">4.3 cm x 2.3 cm </span><span class=\"spark-nlp-display-entity-type\">TumorSize</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> in diameter, and the first-stage diagnosis was \"The solid </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8AC64CB3\"><span class=\"spark-nlp-display-entity-name\">masses </span><span class=\"spark-nlp-display-entity-type\">Tumor_Finding</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #8AC64CFF\">C76.1 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #8AC64CCC\">thorax</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> in the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #302C98B3\"><span class=\"spark-nlp-display-entity-name\">left </span><span class=\"spark-nlp-display-entity-type\">Direction</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #A2496AB3\"><span class=\"spark-nlp-display-entity-name\">axilla </span><span class=\"spark-nlp-display-entity-type\">SiteOtherBodyPart</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A2496AFF\">C50.6 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A2496ACC\">axillary tail of breast</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">.\" </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">He </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> then went to the surgical department for further examination and treatment. Physical examination in the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #302C98B3\"><span class=\"spark-nlp-display-entity-name\">left </span><span class=\"spark-nlp-display-entity-type\">Direction</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #A2496AB3\"><span class=\"spark-nlp-display-entity-name\">axilla </span><span class=\"spark-nlp-display-entity-type\">SiteOtherBodyPart</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A2496AFF\">C50.6 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A2496ACC\">axillary tail of breast</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> showed 2 rigid, mobile, painless </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8AC64CB3\"><span class=\"spark-nlp-display-entity-name\">masses </span><span class=\"spark-nlp-display-entity-type\">Tumor_Finding</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #8AC64CFF\">C76.1 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #8AC64CCC\">thorax</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> measuring approximately </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #6C8F7AB3\"><span class=\"spark-nlp-display-entity-name\">5 cm </span><span class=\"spark-nlp-display-entity-type\">TumorSize</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> in diameter, and the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #A2496AB3\"><span class=\"spark-nlp-display-entity-name\">skin </span><span class=\"spark-nlp-display-entity-type\">SiteOtherBodyPart</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A2496AFF\">C44 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A2496ACC\">skin</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> covering the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8AC64CB3\"><span class=\"spark-nlp-display-entity-name\">masses </span><span class=\"spark-nlp-display-entity-type\">Tumor_Finding</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #8AC64CFF\">C76.1 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #8AC64CCC\">thorax</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> was normal. After admission to the hospital, all </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8AC64CB3\"><span class=\"spark-nlp-display-entity-name\">tumor </span><span class=\"spark-nlp-display-entity-type\">Tumor_Finding</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #8AC64CFF\">8000/1 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #8AC64CCC\">tumor</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> markers, such as serum </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #95B313B3\"><span class=\"spark-nlp-display-entity-name\">carcinoembryonic antigen </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #95B313B3\"><span class=\"spark-nlp-display-entity-name\">CEA </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">), </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #95B313B3\"><span class=\"spark-nlp-display-entity-name\">neuron-specific enolase </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #95B313B3\"><span class=\"spark-nlp-display-entity-name\">NSE </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">), </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #95B313B3\"><span class=\"spark-nlp-display-entity-name\">alpha fetoprotein </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #95B313B3\"><span class=\"spark-nlp-display-entity-name\">AFP </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">), </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #95B313B3\"><span class=\"spark-nlp-display-entity-name\">prostate specific antigen </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #95B313B3\"><span class=\"spark-nlp-display-entity-name\">PSA </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">), </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #95B313B3\"><span class=\"spark-nlp-display-entity-name\">cytokeratin 19 fragment </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #95B313B3\"><span class=\"spark-nlp-display-entity-name\">Cyfra21-1 </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">), </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #95B313B3\"><span class=\"spark-nlp-display-entity-name\">carbohydrate antigen 19-9 </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #95B313B3\"><span class=\"spark-nlp-display-entity-name\">CA19-9 </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">), and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #95B313B3\"><span class=\"spark-nlp-display-entity-name\">carbohydrate antigen 72-4 </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #95B313B3\"><span class=\"spark-nlp-display-entity-name\">CA72-4 </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">), were within normal ranges. Both routine hematological and biochemical parameters were normal. On </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #a6b1e1B3\"><span class=\"spark-nlp-display-entity-name\">March 16, 2016 </span><span class=\"spark-nlp-display-entity-type\">Date</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, the patient underwent </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">his </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #6D5A37B3\"><span class=\"spark-nlp-display-entity-name\">first surgery </span><span class=\"spark-nlp-display-entity-type\">CancerSurgery</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> for </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #6D5A37B3\"><span class=\"spark-nlp-display-entity-name\">axillary neoplasm resection </span><span class=\"spark-nlp-display-entity-type\">CancerSurgery</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #302C98B3\"><span class=\"spark-nlp-display-entity-name\">left </span><span class=\"spark-nlp-display-entity-type\">Direction</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #6D5A37B3\"><span class=\"spark-nlp-display-entity-name\">axillary lymph node dissection </span><span class=\"spark-nlp-display-entity-type\">CancerSurgery</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #6D5A37B3\"><span class=\"spark-nlp-display-entity-name\">ALND </span><span class=\"spark-nlp-display-entity-type\">CancerSurgery</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">). The pathological report of the local hospital (with consultation from the superior hospital expert) stated that only </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #940F5BB3\"><span class=\"spark-nlp-display-entity-name\">metastatic </span><span class=\"spark-nlp-display-entity-type\">Metastasis</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #940F5BFF\">8000/6 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #940F5BCC\">tumor, metastatic</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #A49B3CB3\"><span class=\"spark-nlp-display-entity-name\">lymph nodes </span><span class=\"spark-nlp-display-entity-type\">SiteLymphNode</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A49B3CFF\">C77 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A49B3CCC\">lymph nodes</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> were found in the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #302C98B3\"><span class=\"spark-nlp-display-entity-name\">left </span><span class=\"spark-nlp-display-entity-type\">Direction</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #A2496AB3\"><span class=\"spark-nlp-display-entity-name\">axilla </span><span class=\"spark-nlp-display-entity-type\">SiteOtherBodyPart</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A2496AFF\">C50.6 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A2496ACC\">axillary tail of breast</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> with no suspicious </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8AC64CB3\"><span class=\"spark-nlp-display-entity-name\">lesions </span><span class=\"spark-nlp-display-entity-type\">Tumor_Finding</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #8AC64CFF\">C76.8 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #8AC64CCC\">overlapping lesion of ill-defined sites</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> in the resected specimen. A </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #3B800DB3\"><span class=\"spark-nlp-display-entity-name\">poorly differentiated </span><span class=\"spark-nlp-display-entity-type\">HistologicalType</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #3B800DFF\">C39.9 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #3B800DCC\">ill-defined sites within respiratory system</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #757E7DB3\"><span class=\"spark-nlp-display-entity-name\">carcinoma </span><span class=\"spark-nlp-display-entity-type\">CancerDx</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #757E7DFF\">8010/3 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #757E7DCC\">carcinoma</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> was found in the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #A49B3CB3\"><span class=\"spark-nlp-display-entity-name\">lymph nodes </span><span class=\"spark-nlp-display-entity-type\">SiteLymphNode</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A49B3CFF\">C77 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A49B3CCC\">lymph nodes</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #3B800DB3\"><span class=\"spark-nlp-display-entity-name\">infiltrating </span><span class=\"spark-nlp-display-entity-type\">HistologicalType</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #3B800DFF\">8600/0 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #3B800DCC\">thecoma</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #3B800DB3\"><span class=\"spark-nlp-display-entity-name\">ductal </span><span class=\"spark-nlp-display-entity-type\">HistologicalType</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #3B800DFF\">8500/2 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #3B800DCC\">dcis</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #757E7DB3\"><span class=\"spark-nlp-display-entity-name\">carcinoma </span><span class=\"spark-nlp-display-entity-type\">CancerDx</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #757E7DFF\">8010/3 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #757E7DCC\">carcinoma</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #757E7DB3\"><span class=\"spark-nlp-display-entity-name\">IDC </span><span class=\"spark-nlp-display-entity-type\">CancerDx</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #757E7DFF\">9983/3 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #757E7DCC\">raeb i</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">; 14 out of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #26328CB3\"><span class=\"spark-nlp-display-entity-name\">15 dissected axillary lymph nodes </span><span class=\"spark-nlp-display-entity-type\">Adenopathy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #26328CFF\">9010/0-C50.5 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #26328CCC\">fibroadenoma, of lower-outer quadrant of breast</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> showed </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #940F5BB3\"><span class=\"spark-nlp-display-entity-name\">metastasis </span><span class=\"spark-nlp-display-entity-type\">Metastasis</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #940F5BFF\">8000/6 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #940F5BCC\">tumor, metastatic</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">), and according to </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #AF6459B3\"><span class=\"spark-nlp-display-entity-name\">IHC staining </span><span class=\"spark-nlp-display-entity-type\">PathologyTest</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, the probability that it </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #940F5BB3\"><span class=\"spark-nlp-display-entity-name\">metastasized </span><span class=\"spark-nlp-display-entity-type\">Metastasis</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #940F5BFF\">8000/6 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #940F5BCC\">tumor, metastatic</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> from </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #757E7DB3\"><span class=\"spark-nlp-display-entity-name\">breast cancer </span><span class=\"spark-nlp-display-entity-type\">CancerDx</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #757E7DFF\">8010/3-C50.9 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #757E7DCC\">carcinoma, of breast</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> could not be ruled out. The </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #AF6459B3\"><span class=\"spark-nlp-display-entity-name\">IHC </span><span class=\"spark-nlp-display-entity-type\">PathologyTest</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> results were </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #07990CB3\"><span class=\"spark-nlp-display-entity-name\">positive </span><span class=\"spark-nlp-display-entity-type\">Biomarker_Result</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> for </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #95B313B3\"><span class=\"spark-nlp-display-entity-name\">cytokeratin </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #95B313B3\"><span class=\"spark-nlp-display-entity-name\">CK </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">), </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #95B313B3\"><span class=\"spark-nlp-display-entity-name\">gross cystic disease fluid protein 15 </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #95B313B3\"><span class=\"spark-nlp-display-entity-name\">GCDFP-15 </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">) and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9D8326B3\"><span class=\"spark-nlp-display-entity-name\">human epidermal receptor 2 </span><span class=\"spark-nlp-display-entity-type\">Oncogene</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9D8326FF\">843 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9D8326CC\">mucoepidermoid neoplasms</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9D8326B3\"><span class=\"spark-nlp-display-entity-name\">Her-2 </span><span class=\"spark-nlp-display-entity-type\">Oncogene</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9D8326FF\">C50.0 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9D8326CC\">nipple</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">) (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #07990CB3\"><span class=\"spark-nlp-display-entity-name\">++ </span><span class=\"spark-nlp-display-entity-type\">Biomarker_Result</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">) and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #07990CB3\"><span class=\"spark-nlp-display-entity-name\">negative </span><span class=\"spark-nlp-display-entity-type\">Biomarker_Result</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> for </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #95B313B3\"><span class=\"spark-nlp-display-entity-name\">estrogen receptor </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #95B313B3\"><span class=\"spark-nlp-display-entity-name\">ER </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">), </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #95B313B3\"><span class=\"spark-nlp-display-entity-name\">progesterone receptor </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #95B313B3\"><span class=\"spark-nlp-display-entity-name\">PR </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">), </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #95B313B3\"><span class=\"spark-nlp-display-entity-name\">CK5/6 </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #95B313B3\"><span class=\"spark-nlp-display-entity-name\">CK20 </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #95B313B3\"><span class=\"spark-nlp-display-entity-name\">caudal-related homeobox transcription factor 2 </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #95B313B3\"><span class=\"spark-nlp-display-entity-name\">CDX-2 </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">), </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #95B313B3\"><span class=\"spark-nlp-display-entity-name\">P63 </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #95B313B3\"><span class=\"spark-nlp-display-entity-name\">thyroid transcription factor 1 </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #95B313B3\"><span class=\"spark-nlp-display-entity-name\">TTF-1 </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">), </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #95B313B3\"><span class=\"spark-nlp-display-entity-name\">synaptophysin </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #95B313B3\"><span class=\"spark-nlp-display-entity-name\">Syn </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">), </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #95B313B3\"><span class=\"spark-nlp-display-entity-name\">chromogranin </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> A (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #95B313B3\"><span class=\"spark-nlp-display-entity-name\">CgA </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">), and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #95B313B3\"><span class=\"spark-nlp-display-entity-name\">S100 </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. A </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8F9F33B3\"><span class=\"spark-nlp-display-entity-name\">chest computed tomography </span><span class=\"spark-nlp-display-entity-type\">ImagingTest</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8F9F33B3\"><span class=\"spark-nlp-display-entity-name\">CT </span><span class=\"spark-nlp-display-entity-type\">ImagingTest</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">) </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8F9F33B3\"><span class=\"spark-nlp-display-entity-name\">scan </span><span class=\"spark-nlp-display-entity-type\">ImagingTest</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> was performed in the local hospital </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #4E5E71B3\"><span class=\"spark-nlp-display-entity-name\">8 days after </span><span class=\"spark-nlp-display-entity-type\">RelativeDate</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> the operation, and multiple </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #26328CB3\"><span class=\"spark-nlp-display-entity-name\">enlarged lymph nodes </span><span class=\"spark-nlp-display-entity-type\">Adenopathy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #26328CFF\">8001/3-C77.8 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #26328CCC\">tumor cells, malignant of lymph nodes of multiple regions</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> were shown in the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #302C98B3\"><span class=\"spark-nlp-display-entity-name\">left </span><span class=\"spark-nlp-display-entity-type\">Direction</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #A2496AB3\"><span class=\"spark-nlp-display-entity-name\">axillary </span><span class=\"spark-nlp-display-entity-type\">SiteOtherBodyPart</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A2496AFF\">C21.0 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A2496ACC\">anus</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #A2496AB3\"><span class=\"spark-nlp-display-entity-name\">infraclavicular regions </span><span class=\"spark-nlp-display-entity-type\">SiteOtherBodyPart</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A2496AFF\">C13.0 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A2496ACC\">postcricoid region</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (Fig. 2). The patient did not receive further treatment and was discharged without any complications on </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #a6b1e1B3\"><span class=\"spark-nlp-display-entity-name\">March 26, 2016 </span><span class=\"spark-nlp-display-entity-type\">Date</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #4E5E71B3\"><span class=\"spark-nlp-display-entity-name\">Two days later </span><span class=\"spark-nlp-display-entity-type\">RelativeDate</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">he </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> reported to a superior hospital and underwent a </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8F9F33B3\"><span class=\"spark-nlp-display-entity-name\">positron emission tomography </span><span class=\"spark-nlp-display-entity-type\">ImagingTest</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> with integrated </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8F9F33B3\"><span class=\"spark-nlp-display-entity-name\">computed tomography </span><span class=\"spark-nlp-display-entity-type\">ImagingTest</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8F9F33B3\"><span class=\"spark-nlp-display-entity-name\">PET-CT </span><span class=\"spark-nlp-display-entity-type\">ImagingTest</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">) </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8F9F33B3\"><span class=\"spark-nlp-display-entity-name\">scan of the entire body </span><span class=\"spark-nlp-display-entity-type\">ImagingTest</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. The </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8F9F33B3\"><span class=\"spark-nlp-display-entity-name\">scan </span><span class=\"spark-nlp-display-entity-type\">ImagingTest</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> showed several </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8AC64CB3\"><span class=\"spark-nlp-display-entity-name\">lesions </span><span class=\"spark-nlp-display-entity-type\">Tumor_Finding</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #8AC64CFF\">C76.8 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #8AC64CCC\">overlapping lesion of ill-defined sites</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> with increased uptake in the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #302C98B3\"><span class=\"spark-nlp-display-entity-name\">left </span><span class=\"spark-nlp-display-entity-type\">Direction</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #A2496AB3\"><span class=\"spark-nlp-display-entity-name\">axillary </span><span class=\"spark-nlp-display-entity-type\">SiteOtherBodyPart</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A2496AFF\">C21.0 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A2496ACC\">anus</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #A2496AB3\"><span class=\"spark-nlp-display-entity-name\">infraclavicular regions </span><span class=\"spark-nlp-display-entity-type\">SiteOtherBodyPart</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A2496AFF\">C13.0 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A2496ACC\">postcricoid region</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (Fig. 3), but no </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #A59546B3\"><span class=\"spark-nlp-display-entity-name\">malignant </span><span class=\"spark-nlp-display-entity-type\">SiteBreast</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A59546FF\">8000/3 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A59546CC\">malignancy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8AC64CB3\"><span class=\"spark-nlp-display-entity-name\">lesions </span><span class=\"spark-nlp-display-entity-type\">Tumor_Finding</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #8AC64CFF\">C76.8 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #8AC64CCC\">overlapping lesion of ill-defined sites</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> in other organs, especially in the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #A59546B3\"><span class=\"spark-nlp-display-entity-name\">mammary glands </span><span class=\"spark-nlp-display-entity-type\">SiteBreast</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A59546FF\">C50.6 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A59546CC\">axillary tail of breast</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. The </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8F9F33B3\"><span class=\"spark-nlp-display-entity-name\">US examination </span><span class=\"spark-nlp-display-entity-type\">ImagingTest</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> on the same day also showed no </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8AC64CB3\"><span class=\"spark-nlp-display-entity-name\">lesions </span><span class=\"spark-nlp-display-entity-type\">Tumor_Finding</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #8AC64CFF\">C76.8 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #8AC64CCC\">overlapping lesion of ill-defined sites</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> on the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #A59546B3\"><span class=\"spark-nlp-display-entity-name\">breast </span><span class=\"spark-nlp-display-entity-type\">SiteBreast</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A59546FF\">C50 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A59546CC\">breast</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, and in addition, there was no manifestation of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #757E7DB3\"><span class=\"spark-nlp-display-entity-name\">accessory breast or ectopic breast </span><span class=\"spark-nlp-display-entity-type\">CancerDx</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #757E7DFF\">C50.8 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #757E7DCC\">overlapping lesion of breast</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> in the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #A2496AB3\"><span class=\"spark-nlp-display-entity-name\">axilla </span><span class=\"spark-nlp-display-entity-type\">SiteOtherBodyPart</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A2496AFF\">C50.6 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A2496ACC\">axillary tail of breast</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8F9F33B3\"><span class=\"spark-nlp-display-entity-name\">Mammography </span><span class=\"spark-nlp-display-entity-type\">ImagingTest</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> was strongly recommended but the patient declined.<br><br>On </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #a6b1e1B3\"><span class=\"spark-nlp-display-entity-name\">April 4, 2016 </span><span class=\"spark-nlp-display-entity-type\">Date</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, the patient presented to our hospital. </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">He </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> had no history of disease other than an </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #6D5A37B3\"><span class=\"spark-nlp-display-entity-name\">appendectomy </span><span class=\"spark-nlp-display-entity-type\">CancerSurgery</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #4E5E71B3\"><span class=\"spark-nlp-display-entity-name\">3 years ago </span><span class=\"spark-nlp-display-entity-type\">RelativeDate</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, and no history of medication, particularly </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #667786B3\"><span class=\"spark-nlp-display-entity-name\">hormonal drugs </span><span class=\"spark-nlp-display-entity-type\">HormonalTherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">He </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> had an 8 pack-years smoking history and was a nondrinker. </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">His </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">mother </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> had </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #213759B3\"><span class=\"spark-nlp-display-entity-name\">died </span><span class=\"spark-nlp-display-entity-type\">Death_Entity</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #757E7DB3\"><span class=\"spark-nlp-display-entity-name\">gastric cancer </span><span class=\"spark-nlp-display-entity-type\">CancerDx</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #757E7DFF\">8010/3-C16.9 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #757E7DCC\">carcinoma, of stomach</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">his </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">father </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> of heart attack. In a physical examination, a 6-cm surgical scar was found on the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #302C98B3\"><span class=\"spark-nlp-display-entity-name\">left </span><span class=\"spark-nlp-display-entity-type\">Direction</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #A2496AB3\"><span class=\"spark-nlp-display-entity-name\">axilla </span><span class=\"spark-nlp-display-entity-type\">SiteOtherBodyPart</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A2496AFF\">C50.6 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A2496ACC\">axillary tail of breast</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">; around the scar, several palpable rigid </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8AC64CB3\"><span class=\"spark-nlp-display-entity-name\">nodules </span><span class=\"spark-nlp-display-entity-type\">Tumor_Finding</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #8AC64CFF\">8720/0 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #8AC64CCC\">nevus</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> were found under the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #A2496AB3\"><span class=\"spark-nlp-display-entity-name\">skin </span><span class=\"spark-nlp-display-entity-type\">SiteOtherBodyPart</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A2496AFF\">C44 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A2496ACC\">skin</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. No symptoms were found in either </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #A59546B3\"><span class=\"spark-nlp-display-entity-name\">breasts </span><span class=\"spark-nlp-display-entity-type\">SiteBreast</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A59546FF\">C50 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A59546CC\">breast</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> or in other organs. Considering all the results above, pathologists and oncologists eventually concluded that this was a case of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">male </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #757E7DB3\"><span class=\"spark-nlp-display-entity-name\">OBC </span><span class=\"spark-nlp-display-entity-type\">CancerDx</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #757E7DFF\">C69.6 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #757E7DCC\">orbit</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. We recommended a </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #6D5A37B3\"><span class=\"spark-nlp-display-entity-name\">modified radical mastectomy </span><span class=\"spark-nlp-display-entity-type\">CancerSurgery</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, but </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">he </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> refused the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #6D5A37B3\"><span class=\"spark-nlp-display-entity-name\">mastectomy </span><span class=\"spark-nlp-display-entity-type\">CancerSurgery</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> except for </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #6D5A37B3\"><span class=\"spark-nlp-display-entity-name\">ALND </span><span class=\"spark-nlp-display-entity-type\">CancerSurgery</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. On </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #a6b1e1B3\"><span class=\"spark-nlp-display-entity-name\">April 7, 2016 </span><span class=\"spark-nlp-display-entity-type\">Date</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">he </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> underwent </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">his </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #6D5A37B3\"><span class=\"spark-nlp-display-entity-name\">second surgery </span><span class=\"spark-nlp-display-entity-type\">CancerSurgery</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #AF6459B3\"><span class=\"spark-nlp-display-entity-name\">Histological examination of paraffin sections </span><span class=\"spark-nlp-display-entity-type\">PathologyTest</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #AF6459B3\"><span class=\"spark-nlp-display-entity-name\">hematoxylin and eosin </span><span class=\"spark-nlp-display-entity-type\">PathologyTest</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (HE) staining showed that only the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #302C98B3\"><span class=\"spark-nlp-display-entity-name\">left </span><span class=\"spark-nlp-display-entity-type\">Direction</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #A2496AB3\"><span class=\"spark-nlp-display-entity-name\">axillary </span><span class=\"spark-nlp-display-entity-type\">SiteOtherBodyPart</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A2496AFF\">C21.0 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A2496ACC\">anus</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (levels I and II) and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #A2496AB3\"><span class=\"spark-nlp-display-entity-name\">infraclavicular </span><span class=\"spark-nlp-display-entity-type\">SiteOtherBodyPart</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A2496AFF\">C09.0 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A2496ACC\">tonsillar fossa</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (level III) </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #A49B3CB3\"><span class=\"spark-nlp-display-entity-name\">lymph nodes </span><span class=\"spark-nlp-display-entity-type\">SiteLymphNode</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A49B3CFF\">C77 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A49B3CCC\">lymph nodes</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> were </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #BAB2B1B3\"><span class=\"spark-nlp-display-entity-name\">invaded </span><span class=\"spark-nlp-display-entity-type\">Invasion</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #BAB2B1FF\">C21.0 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #BAB2B1CC\">anus</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> by </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #757E7DB3\"><span class=\"spark-nlp-display-entity-name\">IDC </span><span class=\"spark-nlp-display-entity-type\">CancerDx</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #757E7DFF\">9983/3 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #757E7DCC\">raeb i</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, but no other </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8AC64CB3\"><span class=\"spark-nlp-display-entity-name\">lesions </span><span class=\"spark-nlp-display-entity-type\">Tumor_Finding</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #8AC64CFF\">C76.8 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #8AC64CCC\">overlapping lesion of ill-defined sites</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> were found in the rest of the specimen. The </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8AC64CB3\"><span class=\"spark-nlp-display-entity-name\">tumor </span><span class=\"spark-nlp-display-entity-type\">Tumor_Finding</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #8AC64CFF\">8000/1 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #8AC64CCC\">tumor</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #A49B3CB3\"><span class=\"spark-nlp-display-entity-name\">node </span><span class=\"spark-nlp-display-entity-type\">SiteLymphNode</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A49B3CFF\">9983/3 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A49B3CCC\">raeb i</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #940F5BB3\"><span class=\"spark-nlp-display-entity-name\">metastasis </span><span class=\"spark-nlp-display-entity-type\">Metastasis</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #940F5BFF\">8000/6 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #940F5BCC\">tumor, metastatic</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (TNM) classification was </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #056C24B3\"><span class=\"spark-nlp-display-entity-name\">T0N3aM0 Stage IIIC </span><span class=\"spark-nlp-display-entity-type\">Staging</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, according to 7th American Joint Committee on Cancer (AJCC) staging system of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #757E7DB3\"><span class=\"spark-nlp-display-entity-name\">breast cancer </span><span class=\"spark-nlp-display-entity-type\">CancerDx</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #757E7DFF\">8010/3-C50.9 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #757E7DCC\">carcinoma, of breast</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #AF6459B3\"><span class=\"spark-nlp-display-entity-name\">Histological examination </span><span class=\"spark-nlp-display-entity-type\">PathologyTest</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> showed that the structure of the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #A49B3CB3\"><span class=\"spark-nlp-display-entity-name\">lymph node </span><span class=\"spark-nlp-display-entity-type\">SiteLymphNode</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A49B3CFF\">C77.9 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A49B3CCC\">lymph node</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> was destroyed, and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #505FB2B3\"><span class=\"spark-nlp-display-entity-name\">tumor cells with no clear boundaries were arranged in a prominent massive </span><span class=\"spark-nlp-display-entity-type\">Pathology_Result</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #505FB2FF\">8003/3-C76.8 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #505FB2CC\">malignant tumor, giant cell type of overlapping lesion of ill-defined sites</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, diffusive, and nesting pattern. They were polygonal in shape, with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #505FB2B3\"><span class=\"spark-nlp-display-entity-name\">abundant pink cytoplasm and large oval nuclei </span><span class=\"spark-nlp-display-entity-type\">Pathology_Result</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #505FB2FF\">8093/3 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #505FB2CC\">fibroepithelioma of pinkus type</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (Figs. 4 and 5). </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #AF6459B3\"><span class=\"spark-nlp-display-entity-name\">IHC staining </span><span class=\"spark-nlp-display-entity-type\">PathologyTest</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (Figs. 6-8) showed </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #07990CB3\"><span class=\"spark-nlp-display-entity-name\">positivity </span><span class=\"spark-nlp-display-entity-type\">Biomarker_Result</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> for </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #95B313B3\"><span class=\"spark-nlp-display-entity-name\">CK7 </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #95B313B3\"><span class=\"spark-nlp-display-entity-name\">GCDFP-15 </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #95B313B3\"><span class=\"spark-nlp-display-entity-name\">EMA </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #95B313B3\"><span class=\"spark-nlp-display-entity-name\">CEA </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, suspicious </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #07990CB3\"><span class=\"spark-nlp-display-entity-name\">positivity </span><span class=\"spark-nlp-display-entity-type\">Biomarker_Result</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> for </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9D8326B3\"><span class=\"spark-nlp-display-entity-name\">Her-2 </span><span class=\"spark-nlp-display-entity-type\">Oncogene</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9D8326FF\">C50.0 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9D8326CC\">nipple</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #07990CB3\"><span class=\"spark-nlp-display-entity-name\">++ </span><span class=\"spark-nlp-display-entity-type\">Biomarker_Result</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">), and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #07990CB3\"><span class=\"spark-nlp-display-entity-name\">negativity </span><span class=\"spark-nlp-display-entity-type\">Biomarker_Result</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> for </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #95B313B3\"><span class=\"spark-nlp-display-entity-name\">ER </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #95B313B3\"><span class=\"spark-nlp-display-entity-name\">PR </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #95B313B3\"><span class=\"spark-nlp-display-entity-name\">GATA-binding protein-3 </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #95B313B3\"><span class=\"spark-nlp-display-entity-name\">GATA-3 </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">), </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #95B313B3\"><span class=\"spark-nlp-display-entity-name\">CK20 </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #95B313B3\"><span class=\"spark-nlp-display-entity-name\">mammaglobin </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. The postoperative pathological report again revealed </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #757E7DB3\"><span class=\"spark-nlp-display-entity-name\">carcinoma </span><span class=\"spark-nlp-display-entity-type\">CancerDx</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #757E7DFF\">8010/3 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #757E7DCC\">carcinoma</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> in the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #302C98B3\"><span class=\"spark-nlp-display-entity-name\">left </span><span class=\"spark-nlp-display-entity-type\">Direction</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #A2496AB3\"><span class=\"spark-nlp-display-entity-name\">axillary </span><span class=\"spark-nlp-display-entity-type\">SiteOtherBodyPart</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A2496AFF\">C21.0 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A2496ACC\">anus</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #A49B3CB3\"><span class=\"spark-nlp-display-entity-name\">infraclavicular lymph nodes </span><span class=\"spark-nlp-display-entity-type\">SiteLymphNode</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A49B3CFF\">C77.1 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A49B3CCC\">intrathoracic lymph nodes</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> that </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #940F5BB3\"><span class=\"spark-nlp-display-entity-name\">metastasized </span><span class=\"spark-nlp-display-entity-type\">Metastasis</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #940F5BFF\">8000/6 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #940F5BCC\">tumor, metastatic</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> from the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #A59546B3\"><span class=\"spark-nlp-display-entity-name\">breast </span><span class=\"spark-nlp-display-entity-type\">SiteBreast</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A59546FF\">C50 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A59546CC\">breast</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. Because of the suspicious positivity for </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9D8326B3\"><span class=\"spark-nlp-display-entity-name\">Her-2 </span><span class=\"spark-nlp-display-entity-type\">Oncogene</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9D8326FF\">C50.0 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9D8326CC\">nipple</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #AF6459B3\"><span class=\"spark-nlp-display-entity-name\">fluorescent in situ hybridization </span><span class=\"spark-nlp-display-entity-type\">PathologyTest</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #AF6459B3\"><span class=\"spark-nlp-display-entity-name\">FISH </span><span class=\"spark-nlp-display-entity-type\">PathologyTest</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">) method was strongly recommended but the patient declined because of inability to afford </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #091307B3\"><span class=\"spark-nlp-display-entity-name\">trastuzumab </span><span class=\"spark-nlp-display-entity-type\">TargetedTherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. After the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #6D5A37B3\"><span class=\"spark-nlp-display-entity-name\">surgery </span><span class=\"spark-nlp-display-entity-type\">CancerSurgery</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, the patient subsequently underwent </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #3BC875B3\"><span class=\"spark-nlp-display-entity-name\">adjuvant chemotherapy </span><span class=\"spark-nlp-display-entity-type\">Chemotherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (AT scheme: </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #3BC875B3\"><span class=\"spark-nlp-display-entity-name\">adriamycin </span><span class=\"spark-nlp-display-entity-type\">Chemotherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #0A5386B3\"><span class=\"spark-nlp-display-entity-name\">40 mg </span><span class=\"spark-nlp-display-entity-type\">Dosage</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #6E3A99B3\"><span class=\"spark-nlp-display-entity-name\">day 1-2 </span><span class=\"spark-nlp-display-entity-type\">Cycleday</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">; </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #3BC875B3\"><span class=\"spark-nlp-display-entity-name\">docetaxel </span><span class=\"spark-nlp-display-entity-type\">Chemotherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #0A5386B3\"><span class=\"spark-nlp-display-entity-name\">130 mg </span><span class=\"spark-nlp-display-entity-type\">Dosage</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #6E3A99B3\"><span class=\"spark-nlp-display-entity-name\">day 1 </span><span class=\"spark-nlp-display-entity-type\">Cycleday</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #47BE81B3\"><span class=\"spark-nlp-display-entity-name\">every 3 weeks </span><span class=\"spark-nlp-display-entity-type\">Frequency</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> for </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #42901EB3\"><span class=\"spark-nlp-display-entity-name\">6 cycles </span><span class=\"spark-nlp-display-entity-type\">Cyclecount</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">). The treatment went smoothly, and the patient had good tolerance. Postoperative </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #A5176BB3\"><span class=\"spark-nlp-display-entity-name\">adjuvant radiation therapy </span><span class=\"spark-nlp-display-entity-type\">Radiotherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> on </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">his </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> remaining </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #A59546B3\"><span class=\"spark-nlp-display-entity-name\">breast </span><span class=\"spark-nlp-display-entity-type\">SiteBreast</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A59546FF\">C50 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A59546CC\">breast</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> was delayed due to poor healing of the incision (wound infection). </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">He </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> told us that the wound healed in </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #a6b1e1B3\"><span class=\"spark-nlp-display-entity-name\">December 2016 </span><span class=\"spark-nlp-display-entity-type\">Date</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and that </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">he </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> underwent </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #A5176BB3\"><span class=\"spark-nlp-display-entity-name\">radiation therapy </span><span class=\"spark-nlp-display-entity-type\">Radiotherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> in </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #a6b1e1B3\"><span class=\"spark-nlp-display-entity-name\">February 2017 </span><span class=\"spark-nlp-display-entity-type\">Date</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. The patient is currently being followed up without any signs of recurrence.</span></div>"
            ]
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "## NER + Assertion"
      ],
      "metadata": {
        "id": "2T5XnJRLq5YG"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "assertion_vis.display(annotated_samples[3], label_col = 'chunk', assertion_col = 'assertion')"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "id": "iWBOWeRVhKpI",
        "outputId": "e8817319-6321-4fdf-8de9-a88e90a990c8"
      },
      "execution_count": 61,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<IPython.core.display.HTML object>"
            ],
            "text/html": [
              "\n",
              "<style>\n",
              "    @import url('https://fonts.googleapis.com/css2?family=Montserrat:wght@300;400;500;600;700&display=swap');\n",
              "    @import url('https://fonts.googleapis.com/css2?family=Vistol Regular:wght@300;400;500;600;700&display=swap');\n",
              "    \n",
              "    .spark-nlp-display-scroll-entities {\n",
              "        border: 1px solid #E7EDF0;\n",
              "        border-radius: 3px;\n",
              "        text-align: justify;\n",
              "        \n",
              "    }\n",
              "    .spark-nlp-display-scroll-entities span {  \n",
              "        font-size: 14px;\n",
              "        line-height: 24px;\n",
              "        color: #536B76;\n",
              "        font-family: 'Montserrat', sans-serif !important;\n",
              "    }\n",
              "    \n",
              "    .spark-nlp-display-entity-wrapper{\n",
              "    \n",
              "        display: inline-grid;\n",
              "        text-align: center;\n",
              "        border-radius: 4px;\n",
              "        margin: 0 2px 5px 2px;\n",
              "        padding: 1px\n",
              "    }\n",
              "    .spark-nlp-display-entity-name{\n",
              "        font-size: 14px;\n",
              "        line-height: 24px;\n",
              "        font-family: 'Montserrat', sans-serif !important;\n",
              "        \n",
              "        background: #f1f2f3;\n",
              "        border-width: medium;\n",
              "        text-align: center;\n",
              "        \n",
              "        font-weight: 400;\n",
              "        \n",
              "        border-radius: 5px;\n",
              "        padding: 2px 5px;\n",
              "        display: block;\n",
              "        margin: 3px 2px;\n",
              "    \n",
              "    }\n",
              "    .spark-nlp-display-entity-type{\n",
              "        font-size: 14px;\n",
              "        line-height: 24px;\n",
              "        color: #ffffff;\n",
              "        font-family: 'Montserrat', sans-serif !important;\n",
              "        \n",
              "        text-transform: uppercase;\n",
              "        \n",
              "        font-weight: 500;\n",
              "\n",
              "        display: block;\n",
              "        padding: 3px 5px;\n",
              "    }\n",
              "    \n",
              "    .spark-nlp-display-entity-resolution{\n",
              "        font-size: 14px;\n",
              "        line-height: 24px;\n",
              "        color: #ffffff;\n",
              "        font-family: 'Vistol Regular', sans-serif !important;\n",
              "        \n",
              "        text-transform: uppercase;\n",
              "        \n",
              "        font-weight: 500;\n",
              "\n",
              "        display: block;\n",
              "        padding: 3px 5px;\n",
              "    }\n",
              "    \n",
              "    .spark-nlp-display-others{\n",
              "        font-size: 14px;\n",
              "        line-height: 24px;\n",
              "        font-family: 'Montserrat', sans-serif !important;\n",
              "        \n",
              "        font-weight: 400;\n",
              "    }\n",
              "\n",
              "</style>\n",
              " <span class=\"spark-nlp-display-others\" style=\"background-color: white\">A </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">73-year-old </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">woman </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> presented for treatment recommendations for recurrent </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9062C0B3\"><span class=\"spark-nlp-display-entity-name\">metastatic </span><span class=\"spark-nlp-display-entity-type\">Metastasis</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9062C0FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #7219C2B3\"><span class=\"spark-nlp-display-entity-name\">breast cancer </span><span class=\"spark-nlp-display-entity-type\">CancerDx</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #7219C2FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> in </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #a6b1e1B3\"><span class=\"spark-nlp-display-entity-name\">2010 </span><span class=\"spark-nlp-display-entity-type\">Date</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">She </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> was initially diagnosed with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #5AA05CB3\"><span class=\"spark-nlp-display-entity-name\">ductal </span><span class=\"spark-nlp-display-entity-type\">HistologicalType</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #5AA05CFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #7219C2B3\"><span class=\"spark-nlp-display-entity-name\">carcinoma </span><span class=\"spark-nlp-display-entity-type\">CancerDx</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #7219C2FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> in-situ in </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #a6b1e1B3\"><span class=\"spark-nlp-display-entity-name\">2000 </span><span class=\"spark-nlp-display-entity-type\">Date</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, following an abnormal </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #78449EB3\"><span class=\"spark-nlp-display-entity-name\">mammogram </span><span class=\"spark-nlp-display-entity-type\">ImagingTest</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #78449EFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">Her </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> past medical history was significant for hypertension, hyperthyroidism, and a </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #A04A4FB3\"><span class=\"spark-nlp-display-entity-name\">hysterectomy </span><span class=\"spark-nlp-display-entity-type\">CancerSurgery</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A04A4FFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #B2434DB3\"><span class=\"spark-nlp-display-entity-name\">unilateral </span><span class=\"spark-nlp-display-entity-type\">Direction</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #A04A4FB3\"><span class=\"spark-nlp-display-entity-name\">salpingo-oophorectomy </span><span class=\"spark-nlp-display-entity-type\">CancerSurgery</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A04A4FFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> at age 28. </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">Her </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> home medications were hydrochlorothiazide and levothyroxine, and a prolonged use of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #1896AFB3\"><span class=\"spark-nlp-display-entity-name\">oral </span><span class=\"spark-nlp-display-entity-type\">Route</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #B1BF50B3\"><span class=\"spark-nlp-display-entity-name\">hormone replacement therapy </span><span class=\"spark-nlp-display-entity-type\">HormonalTherapy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #B1BF50FF\">hypothetical </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">Her </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> family history was significant for </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #7219C2B3\"><span class=\"spark-nlp-display-entity-name\">ovarian cancer </span><span class=\"spark-nlp-display-entity-type\">CancerDx</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #7219C2FF\">associated_with_someone_else </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> in </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">her </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">mother </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and maternal </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">aunt </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #7219C2B3\"><span class=\"spark-nlp-display-entity-name\">prostate and colon cancer </span><span class=\"spark-nlp-display-entity-type\">CancerDx</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #7219C2FF\">associated_with_someone_else </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> in </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">her </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">father </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. Given the family history of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #7219C2B3\"><span class=\"spark-nlp-display-entity-name\">ovarian cancer </span><span class=\"spark-nlp-display-entity-type\">CancerDx</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #7219C2FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">her </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> desire to continue </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #B1BF50B3\"><span class=\"spark-nlp-display-entity-name\">hormone replacement therapy </span><span class=\"spark-nlp-display-entity-type\">HormonalTherapy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #B1BF50FF\">hypothetical </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">she </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> underwent </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #B2434DB3\"><span class=\"spark-nlp-display-entity-name\">bilateral </span><span class=\"spark-nlp-display-entity-type\">Direction</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #A04A4FB3\"><span class=\"spark-nlp-display-entity-name\">mastectomy </span><span class=\"spark-nlp-display-entity-type\">CancerSurgery</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A04A4FFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #A04A4FB3\"><span class=\"spark-nlp-display-entity-name\">breast reconstruction </span><span class=\"spark-nlp-display-entity-type\">CancerSurgery</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A04A4FFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and an </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #A04A4FB3\"><span class=\"spark-nlp-display-entity-name\">oophorectomy </span><span class=\"spark-nlp-display-entity-type\">CancerSurgery</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A04A4FFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. Pathology of the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #B2434DB3\"><span class=\"spark-nlp-display-entity-name\">left </span><span class=\"spark-nlp-display-entity-type\">Direction</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9C5D91B3\"><span class=\"spark-nlp-display-entity-name\">breast </span><span class=\"spark-nlp-display-entity-type\">SiteBreast</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> revealed a </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #4401A8B3\"><span class=\"spark-nlp-display-entity-name\">high grade </span><span class=\"spark-nlp-display-entity-type\">Grade</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #502B1DB3\"><span class=\"spark-nlp-display-entity-name\">1 cm </span><span class=\"spark-nlp-display-entity-type\">TumorSize</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #5AA05CB3\"><span class=\"spark-nlp-display-entity-name\">ductal </span><span class=\"spark-nlp-display-entity-type\">HistologicalType</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #5AA05CFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #7219C2B3\"><span class=\"spark-nlp-display-entity-name\">carcinoma </span><span class=\"spark-nlp-display-entity-type\">CancerDx</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #7219C2FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> in-situ. </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">She </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> declined genetic testing and received no further </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #677F82B3\"><span class=\"spark-nlp-display-entity-name\">therapy </span><span class=\"spark-nlp-display-entity-type\">UnspecificTherapy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #677F82FF\">absent </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">.<br><br>In </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #a6b1e1B3\"><span class=\"spark-nlp-display-entity-name\">2010 </span><span class=\"spark-nlp-display-entity-type\">Date</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, the patient underwent an assessment in preparation for an extensive </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #A04A4FB3\"><span class=\"spark-nlp-display-entity-name\">reconstructive foot surgery </span><span class=\"spark-nlp-display-entity-type\">CancerSurgery</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A04A4FFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, which required bone marrow harvesting and stem cell engraftment. A </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #78449EB3\"><span class=\"spark-nlp-display-entity-name\">PET-CT </span><span class=\"spark-nlp-display-entity-type\">ImagingTest</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #78449EFF\">absent </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> revealed a single </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #C7C75DB3\"><span class=\"spark-nlp-display-entity-name\">hypermetabolic mass </span><span class=\"spark-nlp-display-entity-type\">Tumor_Finding</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #C7C75DFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #502B1DB3\"><span class=\"spark-nlp-display-entity-name\">2.3 x1.8 cm </span><span class=\"spark-nlp-display-entity-type\">TumorSize</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> in the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #B2434DB3\"><span class=\"spark-nlp-display-entity-name\">right </span><span class=\"spark-nlp-display-entity-type\">Direction</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #162AC8B3\"><span class=\"spark-nlp-display-entity-name\">lobe </span><span class=\"spark-nlp-display-entity-type\">SiteLung</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">her </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #7CA1A7B3\"><span class=\"spark-nlp-display-entity-name\">liver </span><span class=\"spark-nlp-display-entity-type\">SiteOtherBodyPart</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. A </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8B2912B3\"><span class=\"spark-nlp-display-entity-name\">biopsy </span><span class=\"spark-nlp-display-entity-type\">PathologyTest</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #8B2912FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> revealed this was a </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #5AA05CB3\"><span class=\"spark-nlp-display-entity-name\">poorly differentiated </span><span class=\"spark-nlp-display-entity-type\">HistologicalType</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #5AA05CFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #7219C2B3\"><span class=\"spark-nlp-display-entity-name\">adenocarcinoma </span><span class=\"spark-nlp-display-entity-type\">CancerDx</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #7219C2FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, consistent with a </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #7219C2B3\"><span class=\"spark-nlp-display-entity-name\">breast primary </span><span class=\"spark-nlp-display-entity-type\">CancerDx</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #7219C2FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. It was </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8C7716B3\"><span class=\"spark-nlp-display-entity-name\">ER/PR-positive </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #8C7716FF\">absent </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #BF35A2B3\"><span class=\"spark-nlp-display-entity-name\">HER2-negative </span><span class=\"spark-nlp-display-entity-type\">Oncogene</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #BF35A2FF\">absent </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">She </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> stopped </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">her </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #B1BF50B3\"><span class=\"spark-nlp-display-entity-name\">hormone replacement therapy </span><span class=\"spark-nlp-display-entity-type\">HormonalTherapy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #B1BF50FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> when the diagnosis of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9062C0B3\"><span class=\"spark-nlp-display-entity-name\">metastatic </span><span class=\"spark-nlp-display-entity-type\">Metastasis</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9062C0FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> disease was made. </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">Her </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> physical examination was unremarkable except for prior </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #B2434DB3\"><span class=\"spark-nlp-display-entity-name\">bilateral </span><span class=\"spark-nlp-display-entity-type\">Direction</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #A04A4FB3\"><span class=\"spark-nlp-display-entity-name\">mastectomies </span><span class=\"spark-nlp-display-entity-type\">CancerSurgery</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A04A4FFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #A04A4FB3\"><span class=\"spark-nlp-display-entity-name\">implant-based reconstruction </span><span class=\"spark-nlp-display-entity-type\">CancerSurgery</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A04A4FFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. The patient was started on </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #B1BF50B3\"><span class=\"spark-nlp-display-entity-name\">endocrine therapy </span><span class=\"spark-nlp-display-entity-type\">HormonalTherapy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #B1BF50FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #B1BF50B3\"><span class=\"spark-nlp-display-entity-name\">exemestane </span><span class=\"spark-nlp-display-entity-type\">HormonalTherapy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #B1BF50FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">She </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> described multiple symptoms and was not able to tolerate the medication. </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">She </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> was prescribed </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #B1BF50B3\"><span class=\"spark-nlp-display-entity-name\">anastrozole </span><span class=\"spark-nlp-display-entity-type\">HormonalTherapy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #B1BF50FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, which was associated with a syncopal episode.<br><br>Since the patient had an oligo-metastasis, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">she </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> underwent a </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #A04A4FB3\"><span class=\"spark-nlp-display-entity-name\">partial hepatectomy </span><span class=\"spark-nlp-display-entity-type\">CancerSurgery</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A04A4FFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> in </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #a6b1e1B3\"><span class=\"spark-nlp-display-entity-name\">April 2010 </span><span class=\"spark-nlp-display-entity-type\">Date</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, which revealed </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9062C0B3\"><span class=\"spark-nlp-display-entity-name\">metastatic </span><span class=\"spark-nlp-display-entity-type\">Metastasis</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9062C0FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #7219C2B3\"><span class=\"spark-nlp-display-entity-name\">adenocarcinoma carcinoma </span><span class=\"spark-nlp-display-entity-type\">CancerDx</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #7219C2FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. Following the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #A04A4FB3\"><span class=\"spark-nlp-display-entity-name\">hepatic resection </span><span class=\"spark-nlp-display-entity-type\">CancerSurgery</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A04A4FFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">she </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> declined </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #B1BF50B3\"><span class=\"spark-nlp-display-entity-name\">endocrine therapy </span><span class=\"spark-nlp-display-entity-type\">HormonalTherapy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #B1BF50FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">She </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> was followed regularly with clinical examination and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #78449EB3\"><span class=\"spark-nlp-display-entity-name\">PET-CT imaging </span><span class=\"spark-nlp-display-entity-type\">ImagingTest</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #78449EFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #05A90EB3\"><span class=\"spark-nlp-display-entity-name\">every 3 to 6 months </span><span class=\"spark-nlp-display-entity-type\">Frequency</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #B25054B3\"><span class=\"spark-nlp-display-entity-name\">After 3 years </span><span class=\"spark-nlp-display-entity-type\">RelativeDate</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> of follow up, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #78449EB3\"><span class=\"spark-nlp-display-entity-name\">PET-CT </span><span class=\"spark-nlp-display-entity-type\">ImagingTest</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #78449EFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> revealed a new single hypodense </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #C7C75DB3\"><span class=\"spark-nlp-display-entity-name\">lesion </span><span class=\"spark-nlp-display-entity-type\">Tumor_Finding</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #C7C75DFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> in the liver measuring </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #502B1DB3\"><span class=\"spark-nlp-display-entity-name\">2.6 x 2.8 cm </span><span class=\"spark-nlp-display-entity-type\">TumorSize</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. The patient underwent a </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #A04A4FB3\"><span class=\"spark-nlp-display-entity-name\">second hepatic resection </span><span class=\"spark-nlp-display-entity-type\">CancerSurgery</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A04A4FFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> in </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #a6b1e1B3\"><span class=\"spark-nlp-display-entity-name\">June 2013 </span><span class=\"spark-nlp-display-entity-type\">Date</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">.<br><br>The patient again declined </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #B1BF50B3\"><span class=\"spark-nlp-display-entity-name\">endocrine therapy </span><span class=\"spark-nlp-display-entity-type\">HormonalTherapy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #B1BF50FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and was with no evidence of disease until </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #a6b1e1B3\"><span class=\"spark-nlp-display-entity-name\">June 2014 </span><span class=\"spark-nlp-display-entity-type\">Date</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> when multiple new </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #6C7919B3\"><span class=\"spark-nlp-display-entity-name\">hepatic </span><span class=\"spark-nlp-display-entity-type\">SiteLiver</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #C7C75DB3\"><span class=\"spark-nlp-display-entity-name\">lesions </span><span class=\"spark-nlp-display-entity-type\">Tumor_Finding</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #C7C75DFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> were seen on </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #78449EB3\"><span class=\"spark-nlp-display-entity-name\">PET-CT </span><span class=\"spark-nlp-display-entity-type\">ImagingTest</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #78449EFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. Since </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">she </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> was not a candidate for </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #A04A4FB3\"><span class=\"spark-nlp-display-entity-name\">resection </span><span class=\"spark-nlp-display-entity-type\">CancerSurgery</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A04A4FFF\">possible </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, the patient started </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #B1BF50B3\"><span class=\"spark-nlp-display-entity-name\">letrozole </span><span class=\"spark-nlp-display-entity-type\">HormonalTherapy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #B1BF50FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and has taken the medication despite significant bone pain and dry mouth for </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #3A6692B3\"><span class=\"spark-nlp-display-entity-name\">approximately one year </span><span class=\"spark-nlp-display-entity-type\">Duration</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> when a </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #78449EB3\"><span class=\"spark-nlp-display-entity-name\">PET-CT </span><span class=\"spark-nlp-display-entity-type\">ImagingTest</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #78449EFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> in </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #a6b1e1B3\"><span class=\"spark-nlp-display-entity-name\">June 2015 </span><span class=\"spark-nlp-display-entity-type\">Date</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> demonstrated </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #25ADA6B3\"><span class=\"spark-nlp-display-entity-name\">disease progression </span><span class=\"spark-nlp-display-entity-type\">ResponseToTreatment</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> with multiple </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #6C7919B3\"><span class=\"spark-nlp-display-entity-name\">hepatic </span><span class=\"spark-nlp-display-entity-type\">SiteLiver</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #C7C75DB3\"><span class=\"spark-nlp-display-entity-name\">nodules </span><span class=\"spark-nlp-display-entity-type\">Tumor_Finding</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #C7C75DFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #1A236FB3\"><span class=\"spark-nlp-display-entity-name\">mediastinal lymph nodes </span><span class=\"spark-nlp-display-entity-type\">SiteLymphNode</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (Figure 1). The patient was started on </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #B1BF50B3\"><span class=\"spark-nlp-display-entity-name\">fulvestrant </span><span class=\"spark-nlp-display-entity-type\">HormonalTherapy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #B1BF50FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #605E66B3\"><span class=\"spark-nlp-display-entity-name\">palbociclib </span><span class=\"spark-nlp-display-entity-type\">TargetedTherapy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #605E66FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> in </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #a6b1e1B3\"><span class=\"spark-nlp-display-entity-name\">July 2015 </span><span class=\"spark-nlp-display-entity-type\">Date</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">She </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> received </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #1F749DB3\"><span class=\"spark-nlp-display-entity-name\">one injection </span><span class=\"spark-nlp-display-entity-type\">Cyclecount</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #B1BF50B3\"><span class=\"spark-nlp-display-entity-name\">fulvestrant </span><span class=\"spark-nlp-display-entity-type\">HormonalTherapy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #B1BF50FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and described significant flu-like symptoms, including a cough and diffuse aches. </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">She </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> declined day 15 dose, and did not take </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">her </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #605E66B3\"><span class=\"spark-nlp-display-entity-name\">palbociclib </span><span class=\"spark-nlp-display-entity-type\">TargetedTherapy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #605E66FF\">absent </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">She </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> was agreeable to a second dose of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #B1BF50B3\"><span class=\"spark-nlp-display-entity-name\">fulvestrant </span><span class=\"spark-nlp-display-entity-type\">HormonalTherapy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #B1BF50FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> about </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #3A6692B3\"><span class=\"spark-nlp-display-entity-name\">one month </span><span class=\"spark-nlp-display-entity-type\">Duration</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> following the first injection and also started </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #605E66B3\"><span class=\"spark-nlp-display-entity-name\">palbociclib </span><span class=\"spark-nlp-display-entity-type\">TargetedTherapy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #605E66FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">She </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> again described significant side effects and declined </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #B1BF50B3\"><span class=\"spark-nlp-display-entity-name\">endocrine therapy </span><span class=\"spark-nlp-display-entity-type\">HormonalTherapy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #B1BF50FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">She </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> also declined </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #58B107B3\"><span class=\"spark-nlp-display-entity-name\">chemotherapy </span><span class=\"spark-nlp-display-entity-type\">Chemotherapy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #58B107FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and asked to remain on single agent </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #605E66B3\"><span class=\"spark-nlp-display-entity-name\">palbociclib </span><span class=\"spark-nlp-display-entity-type\">TargetedTherapy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #605E66FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. Given few available options, the patient was maintained on </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #605E66B3\"><span class=\"spark-nlp-display-entity-name\">palbociclib </span><span class=\"spark-nlp-display-entity-type\">TargetedTherapy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #605E66FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, which was adjusted to </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #3A5A7CB3\"><span class=\"spark-nlp-display-entity-name\">100 mg </span><span class=\"spark-nlp-display-entity-type\">Dosage</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> by mouth </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #05A90EB3\"><span class=\"spark-nlp-display-entity-name\">daily </span><span class=\"spark-nlp-display-entity-type\">Frequency</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #3A6692B3\"><span class=\"spark-nlp-display-entity-name\">for 2 weeks </span><span class=\"spark-nlp-display-entity-type\">Duration</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> with a 2-week break based on </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">her </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> complete blood cell counts. </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">She </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> tolerated this dose and schedule well with no neutropenia. An initial follow up </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #78449EB3\"><span class=\"spark-nlp-display-entity-name\">PET-CT </span><span class=\"spark-nlp-display-entity-type\">ImagingTest</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #78449EFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> in </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #a6b1e1B3\"><span class=\"spark-nlp-display-entity-name\">September 2015 </span><span class=\"spark-nlp-display-entity-type\">Date</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> revealed near complete metabolic resolution of the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9062C0B3\"><span class=\"spark-nlp-display-entity-name\">metastatic disease </span><span class=\"spark-nlp-display-entity-type\">Metastasis</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9062C0FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (Figure 2). </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">She </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> remained on </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #605E66B3\"><span class=\"spark-nlp-display-entity-name\">palbociclib </span><span class=\"spark-nlp-display-entity-type\">TargetedTherapy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #605E66FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> alone and was monitored with clinical evaluation and PET-CTs </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #05A90EB3\"><span class=\"spark-nlp-display-entity-name\">every 3 to 6 months </span><span class=\"spark-nlp-display-entity-type\">Frequency</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. However, after </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #25ADA6B3\"><span class=\"spark-nlp-display-entity-name\">progression free </span><span class=\"spark-nlp-display-entity-type\">ResponseToTreatment</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #B25054B3\"><span class=\"spark-nlp-display-entity-name\">interval of 20 months </span><span class=\"spark-nlp-display-entity-type\">RelativeDate</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">her </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #78449EB3\"><span class=\"spark-nlp-display-entity-name\">PET CT </span><span class=\"spark-nlp-display-entity-type\">ImagingTest</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #78449EFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, in </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #a6b1e1B3\"><span class=\"spark-nlp-display-entity-name\">June of 2017 </span><span class=\"spark-nlp-display-entity-type\">Date</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> revealed </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #25ADA6B3\"><span class=\"spark-nlp-display-entity-name\">disease progression </span><span class=\"spark-nlp-display-entity-type\">ResponseToTreatment</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> in the liver and locoregional </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #1A236FB3\"><span class=\"spark-nlp-display-entity-name\">lymph nodes </span><span class=\"spark-nlp-display-entity-type\">SiteLymphNode</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">.</span></div>"
            ]
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "assertion_vis.display(annotated_samples[4], label_col = 'chunk', assertion_col = 'assertion')"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "id": "6l0yZQlqreyd",
        "outputId": "49d84be0-ce0f-4315-a72c-62c40f5b4ec1"
      },
      "execution_count": 63,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<IPython.core.display.HTML object>"
            ],
            "text/html": [
              "\n",
              "<style>\n",
              "    @import url('https://fonts.googleapis.com/css2?family=Montserrat:wght@300;400;500;600;700&display=swap');\n",
              "    @import url('https://fonts.googleapis.com/css2?family=Vistol Regular:wght@300;400;500;600;700&display=swap');\n",
              "    \n",
              "    .spark-nlp-display-scroll-entities {\n",
              "        border: 1px solid #E7EDF0;\n",
              "        border-radius: 3px;\n",
              "        text-align: justify;\n",
              "        \n",
              "    }\n",
              "    .spark-nlp-display-scroll-entities span {  \n",
              "        font-size: 14px;\n",
              "        line-height: 24px;\n",
              "        color: #536B76;\n",
              "        font-family: 'Montserrat', sans-serif !important;\n",
              "    }\n",
              "    \n",
              "    .spark-nlp-display-entity-wrapper{\n",
              "    \n",
              "        display: inline-grid;\n",
              "        text-align: center;\n",
              "        border-radius: 4px;\n",
              "        margin: 0 2px 5px 2px;\n",
              "        padding: 1px\n",
              "    }\n",
              "    .spark-nlp-display-entity-name{\n",
              "        font-size: 14px;\n",
              "        line-height: 24px;\n",
              "        font-family: 'Montserrat', sans-serif !important;\n",
              "        \n",
              "        background: #f1f2f3;\n",
              "        border-width: medium;\n",
              "        text-align: center;\n",
              "        \n",
              "        font-weight: 400;\n",
              "        \n",
              "        border-radius: 5px;\n",
              "        padding: 2px 5px;\n",
              "        display: block;\n",
              "        margin: 3px 2px;\n",
              "    \n",
              "    }\n",
              "    .spark-nlp-display-entity-type{\n",
              "        font-size: 14px;\n",
              "        line-height: 24px;\n",
              "        color: #ffffff;\n",
              "        font-family: 'Montserrat', sans-serif !important;\n",
              "        \n",
              "        text-transform: uppercase;\n",
              "        \n",
              "        font-weight: 500;\n",
              "\n",
              "        display: block;\n",
              "        padding: 3px 5px;\n",
              "    }\n",
              "    \n",
              "    .spark-nlp-display-entity-resolution{\n",
              "        font-size: 14px;\n",
              "        line-height: 24px;\n",
              "        color: #ffffff;\n",
              "        font-family: 'Vistol Regular', sans-serif !important;\n",
              "        \n",
              "        text-transform: uppercase;\n",
              "        \n",
              "        font-weight: 500;\n",
              "\n",
              "        display: block;\n",
              "        padding: 3px 5px;\n",
              "    }\n",
              "    \n",
              "    .spark-nlp-display-others{\n",
              "        font-size: 14px;\n",
              "        line-height: 24px;\n",
              "        font-family: 'Montserrat', sans-serif !important;\n",
              "        \n",
              "        font-weight: 400;\n",
              "    }\n",
              "\n",
              "</style>\n",
              " <span class=\"spark-nlp-display-others\" style=\"background-color: white\">A </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">45-year-old </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">man </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> was treated for </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #47AD28B3\"><span class=\"spark-nlp-display-entity-name\">breast cancer </span><span class=\"spark-nlp-display-entity-type\">CancerDx</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #47AD28FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #239097B3\"><span class=\"spark-nlp-display-entity-name\">5 years prior </span><span class=\"spark-nlp-display-entity-type\">RelativeDate</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> to this report. The </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #5B2E42B3\"><span class=\"spark-nlp-display-entity-name\">tumor </span><span class=\"spark-nlp-display-entity-type\">Tumor_Finding</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #5B2E42FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> was an </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #47AD28B3\"><span class=\"spark-nlp-display-entity-name\">IDC </span><span class=\"spark-nlp-display-entity-type\">CancerDx</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #47AD28FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> classified as </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #983182B3\"><span class=\"spark-nlp-display-entity-name\">pT1N1M0 </span><span class=\"spark-nlp-display-entity-type\">Staging</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #C35301B3\"><span class=\"spark-nlp-display-entity-name\">hormone receptor </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #C35301FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #2C5441B3\"><span class=\"spark-nlp-display-entity-name\">positivity </span><span class=\"spark-nlp-display-entity-type\">Biomarker_Result</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #C35301B3\"><span class=\"spark-nlp-display-entity-name\">estrogen receptor ++ </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #C35301FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #C35301B3\"><span class=\"spark-nlp-display-entity-name\">progesterone receptor </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #C35301FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #C35301B3\"><span class=\"spark-nlp-display-entity-name\">PR </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #C35301FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">) </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #2C5441B3\"><span class=\"spark-nlp-display-entity-name\">+++ </span><span class=\"spark-nlp-display-entity-type\">Biomarker_Result</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #34C817B3\"><span class=\"spark-nlp-display-entity-name\">HER2 </span><span class=\"spark-nlp-display-entity-type\">Oncogene</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #34C817FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #2C5441B3\"><span class=\"spark-nlp-display-entity-name\">+ </span><span class=\"spark-nlp-display-entity-type\">Biomarker_Result</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">) and was treated with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8034B8B3\"><span class=\"spark-nlp-display-entity-name\">surgery </span><span class=\"spark-nlp-display-entity-type\">CancerSurgery</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #8034B8FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8034B8B3\"><span class=\"spark-nlp-display-entity-name\">modified radical mastectomy </span><span class=\"spark-nlp-display-entity-type\">CancerSurgery</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #8034B8FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> of the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #27A17AB3\"><span class=\"spark-nlp-display-entity-name\">right </span><span class=\"spark-nlp-display-entity-type\">Direction</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #2CC4B0B3\"><span class=\"spark-nlp-display-entity-name\">breast </span><span class=\"spark-nlp-display-entity-type\">SiteBreast</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">), </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #1B0218B3\"><span class=\"spark-nlp-display-entity-name\">adjuvant chemotherapy </span><span class=\"spark-nlp-display-entity-type\">Chemotherapy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #1B0218FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #1B0218B3\"><span class=\"spark-nlp-display-entity-name\">adriamycin </span><span class=\"spark-nlp-display-entity-type\">Chemotherapy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #1B0218FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #1B0218B3\"><span class=\"spark-nlp-display-entity-name\">cyclophosphamide </span><span class=\"spark-nlp-display-entity-type\">Chemotherapy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #1B0218FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">), </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #540C3CB3\"><span class=\"spark-nlp-display-entity-name\">radiation therapy </span><span class=\"spark-nlp-display-entity-type\">Radiotherapy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #540C3CFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #AA411AB3\"><span class=\"spark-nlp-display-entity-name\">46 Gy </span><span class=\"spark-nlp-display-entity-type\">RadiationDose</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">) and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #0971B6B3\"><span class=\"spark-nlp-display-entity-name\">endocrine therapy </span><span class=\"spark-nlp-display-entity-type\">HormonalTherapy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #0971B6FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #0971B6B3\"><span class=\"spark-nlp-display-entity-name\">tamoxifen </span><span class=\"spark-nlp-display-entity-type\">HormonalTherapy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #0971B6FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">).<br><br></span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #239097B3\"><span class=\"spark-nlp-display-entity-name\">Two years </span><span class=\"spark-nlp-display-entity-type\">RelativeDate</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> previously, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #A18F5CB3\"><span class=\"spark-nlp-display-entity-name\">whole-body positron emission tomography/computed tomography </span><span class=\"spark-nlp-display-entity-type\">ImagingTest</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A18F5CFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> revealed multiple small </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #5B2E42B3\"><span class=\"spark-nlp-display-entity-name\">nodules </span><span class=\"spark-nlp-display-entity-type\">Tumor_Finding</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #5B2E42FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> in </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #27A17AB3\"><span class=\"spark-nlp-display-entity-name\">both </span><span class=\"spark-nlp-display-entity-type\">Direction</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #BABE30B3\"><span class=\"spark-nlp-display-entity-name\">lungs </span><span class=\"spark-nlp-display-entity-type\">SiteLung</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, but the patient refused additional treatment and was lost to follow-up.<br><br>Subsequently, the patient presented because of a motorcycle accident, and a neurologic exam revealed right hemianopsia with subtle left side weakness. </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #A18F5CB3\"><span class=\"spark-nlp-display-entity-name\">Magnetic resonance imaging </span><span class=\"spark-nlp-display-entity-type\">ImagingTest</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A18F5CFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> revealed a well-enhanced focal solid </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #5B2E42B3\"><span class=\"spark-nlp-display-entity-name\">tumor </span><span class=\"spark-nlp-display-entity-type\">Tumor_Finding</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #5B2E42FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> in the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #27A17AB3\"><span class=\"spark-nlp-display-entity-name\">right </span><span class=\"spark-nlp-display-entity-type\">Direction</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #AD4D13B3\"><span class=\"spark-nlp-display-entity-name\">parietal area </span><span class=\"spark-nlp-display-entity-type\">SiteOtherBodyPart</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #AE1603B3\"><span class=\"spark-nlp-display-entity-name\">5.0 x 4.2 cm </span><span class=\"spark-nlp-display-entity-type\">TumorSize</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">) with the midline shifted to the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #27A17AB3\"><span class=\"spark-nlp-display-entity-name\">left </span><span class=\"spark-nlp-display-entity-type\">Direction</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. (Fig. 1) To confirm the pathology and relieve the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #5B2E42B3\"><span class=\"spark-nlp-display-entity-name\">mass </span><span class=\"spark-nlp-display-entity-type\">Tumor_Finding</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #5B2E42FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> effect, we removed the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #5B2E42B3\"><span class=\"spark-nlp-display-entity-name\">tumor </span><span class=\"spark-nlp-display-entity-type\">Tumor_Finding</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #5B2E42FF\">hypothetical </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. Postoperatively, the patient had no additional neurologic deficits. After </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #734B25B3\"><span class=\"spark-nlp-display-entity-name\">pathological analysis </span><span class=\"spark-nlp-display-entity-type\">PathologyTest</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #734B25FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> confirmed </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #17C1C1B3\"><span class=\"spark-nlp-display-entity-name\">brain </span><span class=\"spark-nlp-display-entity-type\">SiteBone</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #5AC147B3\"><span class=\"spark-nlp-display-entity-name\">metastasis </span><span class=\"spark-nlp-display-entity-type\">Metastasis</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #5AC147FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #47AD28B3\"><span class=\"spark-nlp-display-entity-name\">breast cancer </span><span class=\"spark-nlp-display-entity-type\">CancerDx</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #47AD28FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, the patient was treated with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #540C3CB3\"><span class=\"spark-nlp-display-entity-name\">whole-brain irradiation </span><span class=\"spark-nlp-display-entity-type\">Radiotherapy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #540C3CFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #AA411AB3\"><span class=\"spark-nlp-display-entity-name\">3 Gy x 10 </span><span class=\"spark-nlp-display-entity-type\">RadiationDose</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> fractions for a total dose of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #AA411AB3\"><span class=\"spark-nlp-display-entity-name\">30 Gy </span><span class=\"spark-nlp-display-entity-type\">RadiationDose</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">), which resulted in palliation of symptoms. </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #734B25B3\"><span class=\"spark-nlp-display-entity-name\">Immunohistochemical staining </span><span class=\"spark-nlp-display-entity-type\">PathologyTest</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #734B25FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> revealed </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #17C1C1B3\"><span class=\"spark-nlp-display-entity-name\">cerebral </span><span class=\"spark-nlp-display-entity-type\">SiteBone</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #5AC147B3\"><span class=\"spark-nlp-display-entity-name\">metastasis </span><span class=\"spark-nlp-display-entity-type\">Metastasis</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #5AC147FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #47AD28B3\"><span class=\"spark-nlp-display-entity-name\">breast cancer </span><span class=\"spark-nlp-display-entity-type\">CancerDx</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #47AD28FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #34C817B3\"><span class=\"spark-nlp-display-entity-name\">HER2 </span><span class=\"spark-nlp-display-entity-type\">Oncogene</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #34C817FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> status conversion (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #C35301B3\"><span class=\"spark-nlp-display-entity-name\">estrogen receptor </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #C35301FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #2C5441B3\"><span class=\"spark-nlp-display-entity-name\">+++ </span><span class=\"spark-nlp-display-entity-type\">Biomarker_Result</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #C35301B3\"><span class=\"spark-nlp-display-entity-name\">PR </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #C35301FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #2C5441B3\"><span class=\"spark-nlp-display-entity-name\">+++ </span><span class=\"spark-nlp-display-entity-type\">Biomarker_Result</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #34C817B3\"><span class=\"spark-nlp-display-entity-name\">HER2 </span><span class=\"spark-nlp-display-entity-type\">Oncogene</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #34C817FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> -). (Fig. 2) After that, the patient transferred to oncology department and received </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #1B0218B3\"><span class=\"spark-nlp-display-entity-name\">chemotherapy </span><span class=\"spark-nlp-display-entity-type\">Chemotherapy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #1B0218FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. However, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #239097B3\"><span class=\"spark-nlp-display-entity-name\">2 years later </span><span class=\"spark-nlp-display-entity-type\">RelativeDate</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">he </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> got </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #540C3CB3\"><span class=\"spark-nlp-display-entity-name\">gamma knife radiosurgery </span><span class=\"spark-nlp-display-entity-type\">Radiotherapy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #540C3CFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> due to the recurred </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #AD4D13B3\"><span class=\"spark-nlp-display-entity-name\">brain </span><span class=\"spark-nlp-display-entity-type\">SiteOtherBodyPart</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #5B2E42B3\"><span class=\"spark-nlp-display-entity-name\">lesion </span><span class=\"spark-nlp-display-entity-type\">Tumor_Finding</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #5B2E42FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #1B0218B3\"><span class=\"spark-nlp-display-entity-name\">chemotherapy </span><span class=\"spark-nlp-display-entity-type\">Chemotherapy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #1B0218FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> regimen was changed due to aggravation of multiple </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #BABE30B3\"><span class=\"spark-nlp-display-entity-name\">lung </span><span class=\"spark-nlp-display-entity-type\">SiteLung</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #5AC147B3\"><span class=\"spark-nlp-display-entity-name\">metastases </span><span class=\"spark-nlp-display-entity-type\">Metastasis</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #5AC147FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #239097B3\"><span class=\"spark-nlp-display-entity-name\">One month later </span><span class=\"spark-nlp-display-entity-type\">RelativeDate</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">he </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> discontinued the treatment and opted for hospice care.</span></div>"
            ]
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "assertion_vis.display(annotated_samples[5], label_col = 'chunk', assertion_col = 'assertion')"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "id": "oQ2N8DM_re9E",
        "outputId": "6aa98908-7252-458c-e1c4-29f7f984ca4a"
      },
      "execution_count": 62,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<IPython.core.display.HTML object>"
            ],
            "text/html": [
              "\n",
              "<style>\n",
              "    @import url('https://fonts.googleapis.com/css2?family=Montserrat:wght@300;400;500;600;700&display=swap');\n",
              "    @import url('https://fonts.googleapis.com/css2?family=Vistol Regular:wght@300;400;500;600;700&display=swap');\n",
              "    \n",
              "    .spark-nlp-display-scroll-entities {\n",
              "        border: 1px solid #E7EDF0;\n",
              "        border-radius: 3px;\n",
              "        text-align: justify;\n",
              "        \n",
              "    }\n",
              "    .spark-nlp-display-scroll-entities span {  \n",
              "        font-size: 14px;\n",
              "        line-height: 24px;\n",
              "        color: #536B76;\n",
              "        font-family: 'Montserrat', sans-serif !important;\n",
              "    }\n",
              "    \n",
              "    .spark-nlp-display-entity-wrapper{\n",
              "    \n",
              "        display: inline-grid;\n",
              "        text-align: center;\n",
              "        border-radius: 4px;\n",
              "        margin: 0 2px 5px 2px;\n",
              "        padding: 1px\n",
              "    }\n",
              "    .spark-nlp-display-entity-name{\n",
              "        font-size: 14px;\n",
              "        line-height: 24px;\n",
              "        font-family: 'Montserrat', sans-serif !important;\n",
              "        \n",
              "        background: #f1f2f3;\n",
              "        border-width: medium;\n",
              "        text-align: center;\n",
              "        \n",
              "        font-weight: 400;\n",
              "        \n",
              "        border-radius: 5px;\n",
              "        padding: 2px 5px;\n",
              "        display: block;\n",
              "        margin: 3px 2px;\n",
              "    \n",
              "    }\n",
              "    .spark-nlp-display-entity-type{\n",
              "        font-size: 14px;\n",
              "        line-height: 24px;\n",
              "        color: #ffffff;\n",
              "        font-family: 'Montserrat', sans-serif !important;\n",
              "        \n",
              "        text-transform: uppercase;\n",
              "        \n",
              "        font-weight: 500;\n",
              "\n",
              "        display: block;\n",
              "        padding: 3px 5px;\n",
              "    }\n",
              "    \n",
              "    .spark-nlp-display-entity-resolution{\n",
              "        font-size: 14px;\n",
              "        line-height: 24px;\n",
              "        color: #ffffff;\n",
              "        font-family: 'Vistol Regular', sans-serif !important;\n",
              "        \n",
              "        text-transform: uppercase;\n",
              "        \n",
              "        font-weight: 500;\n",
              "\n",
              "        display: block;\n",
              "        padding: 3px 5px;\n",
              "    }\n",
              "    \n",
              "    .spark-nlp-display-others{\n",
              "        font-size: 14px;\n",
              "        line-height: 24px;\n",
              "        font-family: 'Montserrat', sans-serif !important;\n",
              "        \n",
              "        font-weight: 400;\n",
              "    }\n",
              "\n",
              "</style>\n",
              " <span class=\"spark-nlp-display-others\" style=\"background-color: white\">In </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #a6b1e1B3\"><span class=\"spark-nlp-display-entity-name\">June 2019 </span><span class=\"spark-nlp-display-entity-type\">Date</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, a </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">51-year-old </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> premenopausal patient was diagnosed with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #C66F58B3\"><span class=\"spark-nlp-display-entity-name\">right </span><span class=\"spark-nlp-display-entity-type\">Direction</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #693073B3\"><span class=\"spark-nlp-display-entity-name\">breast cancer </span><span class=\"spark-nlp-display-entity-type\">CancerDx</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #693073FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> through an </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #5775C2B3\"><span class=\"spark-nlp-display-entity-name\">ultrasound-guided core needle biopsy </span><span class=\"spark-nlp-display-entity-type\">PathologyTest</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #5775C2FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> performed on an initial </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9A8C0DB3\"><span class=\"spark-nlp-display-entity-name\">mass </span><span class=\"spark-nlp-display-entity-type\">Tumor_Finding</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9A8C0DFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> of the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #C66F58B3\"><span class=\"spark-nlp-display-entity-name\">right </span><span class=\"spark-nlp-display-entity-type\">Direction</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8F2063B3\"><span class=\"spark-nlp-display-entity-name\">breast </span><span class=\"spark-nlp-display-entity-type\">SiteBreast</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">.<br><br>A fixed </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9620BFB3\"><span class=\"spark-nlp-display-entity-name\">lymph node </span><span class=\"spark-nlp-display-entity-type\">SiteLymphNode</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> in the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #C66F58B3\"><span class=\"spark-nlp-display-entity-name\">ipsilateral </span><span class=\"spark-nlp-display-entity-type\">Direction</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #3A1E6EB3\"><span class=\"spark-nlp-display-entity-name\">axilla </span><span class=\"spark-nlp-display-entity-type\">SiteOtherBodyPart</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> was palpable and was diagnosed as a </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #451FADB3\"><span class=\"spark-nlp-display-entity-name\">metastatic </span><span class=\"spark-nlp-display-entity-type\">Metastasis</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #451FADFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9620BFB3\"><span class=\"spark-nlp-display-entity-name\">lymph node </span><span class=\"spark-nlp-display-entity-type\">SiteLymphNode</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> through </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #5775C2B3\"><span class=\"spark-nlp-display-entity-name\">fine needle aspiration </span><span class=\"spark-nlp-display-entity-type\">PathologyTest</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #5775C2FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">She </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> was diagnosed with clinical </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #42AD3BB3\"><span class=\"spark-nlp-display-entity-name\">stage T2N2 </span><span class=\"spark-nlp-display-entity-type\">Staging</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. The </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #693073B3\"><span class=\"spark-nlp-display-entity-name\">breast cancer </span><span class=\"spark-nlp-display-entity-type\">CancerDx</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #693073FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> subtype was luminal A type and was </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #024694B3\"><span class=\"spark-nlp-display-entity-name\">positive </span><span class=\"spark-nlp-display-entity-type\">Biomarker_Result</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> for </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9DA29EB3\"><span class=\"spark-nlp-display-entity-name\">ER </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9DA29EFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9DA29EB3\"><span class=\"spark-nlp-display-entity-name\">progesterone receptor </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9DA29EFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9DA29EB3\"><span class=\"spark-nlp-display-entity-name\">PR </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9DA29EFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">) and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #024694B3\"><span class=\"spark-nlp-display-entity-name\">negative </span><span class=\"spark-nlp-display-entity-type\">Biomarker_Result</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> for </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9DA29EB3\"><span class=\"spark-nlp-display-entity-name\">HER2/neu </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9DA29EFF\">absent </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9DA29EB3\"><span class=\"spark-nlp-display-entity-name\">Ki-67 marker index < 10% </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9DA29EFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> on </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #5775C2B3\"><span class=\"spark-nlp-display-entity-name\">immunohistochemistry (IHC </span><span class=\"spark-nlp-display-entity-type\">PathologyTest</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #5775C2FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">). </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">She </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> was diagnosed with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #42AD3BB3\"><span class=\"spark-nlp-display-entity-name\">locally advanced </span><span class=\"spark-nlp-display-entity-type\">Staging</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #693073B3\"><span class=\"spark-nlp-display-entity-name\">breast cancer </span><span class=\"spark-nlp-display-entity-type\">CancerDx</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #693073FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. Therefore, we planned </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #3937C7B3\"><span class=\"spark-nlp-display-entity-name\">surgery </span><span class=\"spark-nlp-display-entity-type\">CancerSurgery</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #3937C7FF\">possible </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> after6 </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #2E6B08B3\"><span class=\"spark-nlp-display-entity-name\">cycles </span><span class=\"spark-nlp-display-entity-type\">Cyclecount</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #68A4BEB3\"><span class=\"spark-nlp-display-entity-name\">neoadjuvant chemotherapy </span><span class=\"spark-nlp-display-entity-type\">Chemotherapy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #68A4BEFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> consisting of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #68A4BEB3\"><span class=\"spark-nlp-display-entity-name\">adriamycin </span><span class=\"spark-nlp-display-entity-type\">Chemotherapy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #68A4BEFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #68A4BEB3\"><span class=\"spark-nlp-display-entity-name\">docetaxel </span><span class=\"spark-nlp-display-entity-type\">Chemotherapy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #68A4BEFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #A389C6B3\"><span class=\"spark-nlp-display-entity-name\">60 mg/m2 </span><span class=\"spark-nlp-display-entity-type\">Dosage</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #A389C6B3\"><span class=\"spark-nlp-display-entity-name\">75 mg/m2 </span><span class=\"spark-nlp-display-entity-type\">Dosage</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, respectively). On </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #a6b1e1B3\"><span class=\"spark-nlp-display-entity-name\">June 25, 2019 </span><span class=\"spark-nlp-display-entity-type\">Date</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #68A4BEB3\"><span class=\"spark-nlp-display-entity-name\">neoadjuvant chemotherapy </span><span class=\"spark-nlp-display-entity-type\">Chemotherapy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #68A4BEFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> was started. After </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #2E6B08B3\"><span class=\"spark-nlp-display-entity-name\">3 cycles </span><span class=\"spark-nlp-display-entity-type\">Cyclecount</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffacb7B3\"><span class=\"spark-nlp-display-entity-name\">she </span><span class=\"spark-nlp-display-entity-type\">Gender</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> underwent a </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #2E8E49B3\"><span class=\"spark-nlp-display-entity-name\">breast magnetic resonance imaging </span><span class=\"spark-nlp-display-entity-type\">ImagingTest</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #2E8E49FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #2E8E49B3\"><span class=\"spark-nlp-display-entity-name\">MRI </span><span class=\"spark-nlp-display-entity-type\">ImagingTest</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #2E8E49FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">) and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #2E8E49B3\"><span class=\"spark-nlp-display-entity-name\">ultrasound </span><span class=\"spark-nlp-display-entity-type\">ImagingTest</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #2E8E49FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> as an intermediate evaluation.<br><br>Granulocyte colony-stimulating factor was used after each </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #68A4BEB3\"><span class=\"spark-nlp-display-entity-name\">chemotherapy </span><span class=\"spark-nlp-display-entity-type\">Chemotherapy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #68A4BEFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. During3 rounds of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #68A4BEB3\"><span class=\"spark-nlp-display-entity-name\">neoadjuvant chemotherapy </span><span class=\"spark-nlp-display-entity-type\">Chemotherapy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #68A4BEFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, neutropenia occurred </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #620CB9B3\"><span class=\"spark-nlp-display-entity-name\">twice </span><span class=\"spark-nlp-display-entity-type\">Frequency</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, but febrile neutropenia did not occur and the dose was maintained.<br><br>Compared with the initial study of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #2E8E49B3\"><span class=\"spark-nlp-display-entity-name\">MRI </span><span class=\"spark-nlp-display-entity-type\">ImagingTest</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #2E8E49FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #2E8E49B3\"><span class=\"spark-nlp-display-entity-name\">breast ultrasound </span><span class=\"spark-nlp-display-entity-type\">ImagingTest</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #2E8E49FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #68A4BEB3\"><span class=\"spark-nlp-display-entity-name\">chemotherapy </span><span class=\"spark-nlp-display-entity-type\">Chemotherapy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #68A4BEFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> had no effect on the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8F2063B3\"><span class=\"spark-nlp-display-entity-name\">breast </span><span class=\"spark-nlp-display-entity-type\">SiteBreast</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9A8C0DB3\"><span class=\"spark-nlp-display-entity-name\">mass </span><span class=\"spark-nlp-display-entity-type\">Tumor_Finding</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9A8C0DFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #3A1E6EB3\"><span class=\"spark-nlp-display-entity-name\">axillary </span><span class=\"spark-nlp-display-entity-type\">SiteOtherBodyPart</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #451FADB3\"><span class=\"spark-nlp-display-entity-name\">metastasis </span><span class=\"spark-nlp-display-entity-type\">Metastasis</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #451FADFF\">absent </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. Rather, the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #451FADB3\"><span class=\"spark-nlp-display-entity-name\">metastatic </span><span class=\"spark-nlp-display-entity-type\">Metastasis</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #451FADFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9620BFB3\"><span class=\"spark-nlp-display-entity-name\">axillary lymph node </span><span class=\"spark-nlp-display-entity-type\">SiteLymphNode</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> size increased (Fig. 1).<br><br>Although </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #2E6B08B3\"><span class=\"spark-nlp-display-entity-name\">3 cycles </span><span class=\"spark-nlp-display-entity-type\">Cyclecount</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #68A4BEB3\"><span class=\"spark-nlp-display-entity-name\">chemotherapy </span><span class=\"spark-nlp-display-entity-type\">Chemotherapy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #68A4BEFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> were left, it was expected that the downstaging would be difficult to achieve even after the remaining </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #2E6B08B3\"><span class=\"spark-nlp-display-entity-name\">cycles </span><span class=\"spark-nlp-display-entity-type\">Cyclecount</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">.<br><br>We chose </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #BC0362B3\"><span class=\"spark-nlp-display-entity-name\">palbociclib </span><span class=\"spark-nlp-display-entity-type\">TargetedTherapy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #BC0362FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #BC0362B3\"><span class=\"spark-nlp-display-entity-name\">CDK 4/6 inhibitor </span><span class=\"spark-nlp-display-entity-type\">TargetedTherapy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #BC0362FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">) with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #585A8EB3\"><span class=\"spark-nlp-display-entity-name\">letrozole </span><span class=\"spark-nlp-display-entity-type\">HormonalTherapy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #585A8EFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> administration as </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #796B98B3\"><span class=\"spark-nlp-display-entity-name\">second neo-adjuvant systemic treatment </span><span class=\"spark-nlp-display-entity-type\">UnspecificTherapy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #796B98FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. Monthly </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #585A8EB3\"><span class=\"spark-nlp-display-entity-name\">leuprorelin acetate </span><span class=\"spark-nlp-display-entity-type\">HormonalTherapy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #585A8EFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> was coadministered for ovarian suppression.<br><br>The first dosing began on </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #a6b1e1B3\"><span class=\"spark-nlp-display-entity-name\">September 2, 2019 </span><span class=\"spark-nlp-display-entity-type\">Date</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. In </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #2E6B08B3\"><span class=\"spark-nlp-display-entity-name\">4-week cycles </span><span class=\"spark-nlp-display-entity-type\">Cyclecount</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #BC0362B3\"><span class=\"spark-nlp-display-entity-name\">palbociclib </span><span class=\"spark-nlp-display-entity-type\">TargetedTherapy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #BC0362FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> was administered at </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #A389C6B3\"><span class=\"spark-nlp-display-entity-name\">125 mg </span><span class=\"spark-nlp-display-entity-type\">Dosage</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #620CB9B3\"><span class=\"spark-nlp-display-entity-name\">per day </span><span class=\"spark-nlp-display-entity-type\">Frequency</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, with a 1-week break after </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #97BE26B3\"><span class=\"spark-nlp-display-entity-name\">3 weeks </span><span class=\"spark-nlp-display-entity-type\">Duration</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> of treatment. </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #585A8EB3\"><span class=\"spark-nlp-display-entity-name\">Letrozole </span><span class=\"spark-nlp-display-entity-type\">HormonalTherapy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #585A8EFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> was administered </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #A389C6B3\"><span class=\"spark-nlp-display-entity-name\">2.5 mg </span><span class=\"spark-nlp-display-entity-type\">Dosage</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #620CB9B3\"><span class=\"spark-nlp-display-entity-name\">per day </span><span class=\"spark-nlp-display-entity-type\">Frequency</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and was taken </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #620CB9B3\"><span class=\"spark-nlp-display-entity-name\">daily </span><span class=\"spark-nlp-display-entity-type\">Frequency</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> without interruption. </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #2E8E49B3\"><span class=\"spark-nlp-display-entity-name\">Breast MRI </span><span class=\"spark-nlp-display-entity-type\">ImagingTest</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #2E8E49FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> were performed at 3, 7, and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #4A3D56B3\"><span class=\"spark-nlp-display-entity-name\">11 months </span><span class=\"spark-nlp-display-entity-type\">RelativeDate</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, respectively, during drug administration for </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9A8C0DB3\"><span class=\"spark-nlp-display-entity-name\">tumor </span><span class=\"spark-nlp-display-entity-type\">Tumor_Finding</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9A8C0DFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> evaluation. On the first interim evaluation conducted </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #4A3D56B3\"><span class=\"spark-nlp-display-entity-name\">3 months later </span><span class=\"spark-nlp-display-entity-type\">RelativeDate</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, both the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8F2063B3\"><span class=\"spark-nlp-display-entity-name\">breast </span><span class=\"spark-nlp-display-entity-type\">SiteBreast</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9A8C0DB3\"><span class=\"spark-nlp-display-entity-name\">mass </span><span class=\"spark-nlp-display-entity-type\">Tumor_Finding</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9A8C0DFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9620BFB3\"><span class=\"spark-nlp-display-entity-name\">axillary node </span><span class=\"spark-nlp-display-entity-type\">SiteLymphNode</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> decreased. In a 7-month study, a metal clip was inserted into the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8F2063B3\"><span class=\"spark-nlp-display-entity-name\">breast </span><span class=\"spark-nlp-display-entity-type\">SiteBreast</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9A8C0DB3\"><span class=\"spark-nlp-display-entity-name\">lesion </span><span class=\"spark-nlp-display-entity-type\">Tumor_Finding</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9A8C0DFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. The treatment was performed until </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #a6b1e1B3\"><span class=\"spark-nlp-display-entity-name\">May 13, 2020 </span><span class=\"spark-nlp-display-entity-type\">Date</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #4A3D56B3\"><span class=\"spark-nlp-display-entity-name\">After 11 months </span><span class=\"spark-nlp-display-entity-type\">RelativeDate</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #2E8E49B3\"><span class=\"spark-nlp-display-entity-name\">breast MRI </span><span class=\"spark-nlp-display-entity-type\">ImagingTest</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #2E8E49FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> performed on </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #a6b1e1B3\"><span class=\"spark-nlp-display-entity-name\">June 24, 2020 </span><span class=\"spark-nlp-display-entity-type\">Date</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> before </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #3937C7B3\"><span class=\"spark-nlp-display-entity-name\">surgery </span><span class=\"spark-nlp-display-entity-type\">CancerSurgery</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #3937C7FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, a 0.5-cm residual </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9A8C0DB3\"><span class=\"spark-nlp-display-entity-name\">tumor </span><span class=\"spark-nlp-display-entity-type\">Tumor_Finding</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9A8C0DFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> with a metal clip was observed, and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #451FADB3\"><span class=\"spark-nlp-display-entity-name\">metastatic </span><span class=\"spark-nlp-display-entity-type\">Metastasis</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #451FADFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9620BFB3\"><span class=\"spark-nlp-display-entity-name\">lymph nodes </span><span class=\"spark-nlp-display-entity-type\">SiteLymphNode</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> in the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #3A1E6EB3\"><span class=\"spark-nlp-display-entity-name\">axilla </span><span class=\"spark-nlp-display-entity-type\">SiteOtherBodyPart</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> were no longer observed (Fig. 2.).<br><br></span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #BC0362B3\"><span class=\"spark-nlp-display-entity-name\">Palbociclib </span><span class=\"spark-nlp-display-entity-type\">TargetedTherapy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #BC0362FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #585A8EB3\"><span class=\"spark-nlp-display-entity-name\">letrozole </span><span class=\"spark-nlp-display-entity-type\">HormonalTherapy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #585A8EFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> was administered </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #97BE26B3\"><span class=\"spark-nlp-display-entity-name\">for 10 months </span><span class=\"spark-nlp-display-entity-type\">Duration</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> prior to </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #3937C7B3\"><span class=\"spark-nlp-display-entity-name\">surgery </span><span class=\"spark-nlp-display-entity-type\">CancerSurgery</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #3937C7FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. No side effects such as grade 3 neutropenia or diarrhea occurred. So, there was no discontinuation of the drug due to side effects.<br><br>On </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #a6b1e1B3\"><span class=\"spark-nlp-display-entity-name\">July 1, 2020 </span><span class=\"spark-nlp-display-entity-type\">Date</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #C66F58B3\"><span class=\"spark-nlp-display-entity-name\">right </span><span class=\"spark-nlp-display-entity-type\">Direction</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #3937C7B3\"><span class=\"spark-nlp-display-entity-name\">breast conservation surgery </span><span class=\"spark-nlp-display-entity-type\">CancerSurgery</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #3937C7FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #5775C2B3\"><span class=\"spark-nlp-display-entity-name\">sentinel lymph node biopsy </span><span class=\"spark-nlp-display-entity-type\">PathologyTest</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #5775C2FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> was performed. Through </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #3937C7B3\"><span class=\"spark-nlp-display-entity-name\">surgery </span><span class=\"spark-nlp-display-entity-type\">CancerSurgery</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #3937C7FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, the treatment results of the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #2F75BEB3\"><span class=\"spark-nlp-display-entity-name\">2nd line </span><span class=\"spark-nlp-display-entity-type\">LineOfTherapy</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #BC0362B3\"><span class=\"spark-nlp-display-entity-name\">palbociclib </span><span class=\"spark-nlp-display-entity-type\">TargetedTherapy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #BC0362FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #585A8EB3\"><span class=\"spark-nlp-display-entity-name\">letrozole </span><span class=\"spark-nlp-display-entity-type\">HormonalTherapy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #585A8EFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> were finally evaluated. On </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #5775C2B3\"><span class=\"spark-nlp-display-entity-name\">intraoperative frozen section biopsy </span><span class=\"spark-nlp-display-entity-type\">PathologyTest</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #5775C2FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9620BFB3\"><span class=\"spark-nlp-display-entity-name\">sentinel lymph nodes </span><span class=\"spark-nlp-display-entity-type\">SiteLymphNode</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> were negative for </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #693073B3\"><span class=\"spark-nlp-display-entity-name\">malignancy </span><span class=\"spark-nlp-display-entity-type\">CancerDx</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #693073FF\">absent </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. Based on the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #5775C2B3\"><span class=\"spark-nlp-display-entity-name\">biopsy </span><span class=\"spark-nlp-display-entity-type\">PathologyTest</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #5775C2FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> results, a single-tumor bed was macroscopically identified in a </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #42AD3BB3\"><span class=\"spark-nlp-display-entity-name\">metal-clipped </span><span class=\"spark-nlp-display-entity-type\">Staging</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> area of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #873F02B3\"><span class=\"spark-nlp-display-entity-name\">26 x 15 x 5 mm </span><span class=\"spark-nlp-display-entity-type\">TumorSize</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> corresponding to the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9A8C0DB3\"><span class=\"spark-nlp-display-entity-name\">tumor </span><span class=\"spark-nlp-display-entity-type\">Tumor_Finding</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9A8C0DFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> size before </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #796B98B3\"><span class=\"spark-nlp-display-entity-name\">neoadjuvant treatment </span><span class=\"spark-nlp-display-entity-type\">UnspecificTherapy</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #796B98FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. The entire macroscopic </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9A8C0DB3\"><span class=\"spark-nlp-display-entity-name\">tumor </span><span class=\"spark-nlp-display-entity-type\">Tumor_Finding</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9A8C0DFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> bed was submitted for </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #5775C2B3\"><span class=\"spark-nlp-display-entity-name\">histological mapping </span><span class=\"spark-nlp-display-entity-type\">PathologyTest</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #5775C2FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. However, the microscopic extent of residual </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #693073B3\"><span class=\"spark-nlp-display-entity-name\">cancer </span><span class=\"spark-nlp-display-entity-type\">CancerDx</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #693073FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> did not correlate with the macroscopic measurement of the residual </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9A8C0DB3\"><span class=\"spark-nlp-display-entity-name\">tumor </span><span class=\"spark-nlp-display-entity-type\">Tumor_Finding</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9A8C0DFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> bed, and the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9A8C0DB3\"><span class=\"spark-nlp-display-entity-name\">tumor </span><span class=\"spark-nlp-display-entity-type\">Tumor_Finding</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9A8C0DFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> bed dimensions were revised according to the microscopic findings based on the pathology protocol provided by MD Anderson Cancer Center.<br><br>Cellularity was variable in different fields of the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9A8C0DB3\"><span class=\"spark-nlp-display-entity-name\">tumor </span><span class=\"spark-nlp-display-entity-type\">Tumor_Finding</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9A8C0DFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> bed, and the final cellularity was determined as the average of the estimated proportions in each different microscopic field across the entire area of the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9A8C0DB3\"><span class=\"spark-nlp-display-entity-name\">tumor </span><span class=\"spark-nlp-display-entity-type\">Tumor_Finding</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9A8C0DFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> bed (Fig. 3).<br><br></span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #5775C2B3\"><span class=\"spark-nlp-display-entity-name\">Histologic evaluations </span><span class=\"spark-nlp-display-entity-type\">PathologyTest</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #5775C2FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> were performed for all </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #A68A01B3\"><span class=\"spark-nlp-display-entity-name\">invasive </span><span class=\"spark-nlp-display-entity-type\">HistologicalType</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A68A01FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and in </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #A68A01B3\"><span class=\"spark-nlp-display-entity-name\">situ </span><span class=\"spark-nlp-display-entity-type\">HistologicalType</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A68A01FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #693073B3\"><span class=\"spark-nlp-display-entity-name\">carcinomas </span><span class=\"spark-nlp-display-entity-type\">CancerDx</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #693073FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> according to the original guidelines of the MD Anderson Cancer Center. The overall </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #693073B3\"><span class=\"spark-nlp-display-entity-name\">cancer </span><span class=\"spark-nlp-display-entity-type\">CancerDx</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #693073FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> cellularity of the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #91622AB3\"><span class=\"spark-nlp-display-entity-name\">invasive </span><span class=\"spark-nlp-display-entity-type\">Invasion</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #91622AFF\">possible </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> or in situ component was 6.93%, and the proportion of in situ component was 5.8% within the microscopically revised </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9A8C0DB3\"><span class=\"spark-nlp-display-entity-name\">tumor </span><span class=\"spark-nlp-display-entity-type\">Tumor_Finding</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9A8C0DFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> bed area (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #873F02B3\"><span class=\"spark-nlp-display-entity-name\">8 x 4 mm </span><span class=\"spark-nlp-display-entity-type\">TumorSize</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">). Two </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9620BFB3\"><span class=\"spark-nlp-display-entity-name\">axillary lymph nodes </span><span class=\"spark-nlp-display-entity-type\">SiteLymphNode</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> were dissected and were found to be negative, with no </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #451FADB3\"><span class=\"spark-nlp-display-entity-name\">metastatic </span><span class=\"spark-nlp-display-entity-type\">Metastasis</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #451FADFF\">absent </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9A8C0DB3\"><span class=\"spark-nlp-display-entity-name\">tumor </span><span class=\"spark-nlp-display-entity-type\">Tumor_Finding</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9A8C0DFF\">absent </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> deposition. The calculated RCB was 1.114, and it was classified as </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9DA29EB3\"><span class=\"spark-nlp-display-entity-name\">RCB-1 </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9DA29EFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> via a web-based calculator (www.mdanderson.org/breastcancer_RCB).<br><br></span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #5775C2B3\"><span class=\"spark-nlp-display-entity-name\">IHC </span><span class=\"spark-nlp-display-entity-type\">PathologyTest</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #5775C2FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> results for residual </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9A8C0DB3\"><span class=\"spark-nlp-display-entity-name\">lesions </span><span class=\"spark-nlp-display-entity-type\">Tumor_Finding</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9A8C0DFF\">absent </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> were </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #024694B3\"><span class=\"spark-nlp-display-entity-name\">weakly positive </span><span class=\"spark-nlp-display-entity-type\">Biomarker_Result</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> for </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9DA29EB3\"><span class=\"spark-nlp-display-entity-name\">ER </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9DA29EFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #024694B3\"><span class=\"spark-nlp-display-entity-name\">negative </span><span class=\"spark-nlp-display-entity-type\">Biomarker_Result</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> for </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9DA29EB3\"><span class=\"spark-nlp-display-entity-name\">PR </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9DA29EFF\">absent </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #A41E07B3\"><span class=\"spark-nlp-display-entity-name\">HER2 </span><span class=\"spark-nlp-display-entity-type\">Oncogene</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #A41E07FF\">absent </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">; they were less than </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #024694B3\"><span class=\"spark-nlp-display-entity-name\">10% </span><span class=\"spark-nlp-display-entity-type\">Biomarker_Result</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> for </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9DA29EB3\"><span class=\"spark-nlp-display-entity-name\">Ki67 </span><span class=\"spark-nlp-display-entity-type\">Biomarker</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #9DA29EFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, which were different from the original results.</span></div>"
            ]
          },
          "metadata": {}
        }
      ]
    }
  ]
}
